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Circadian rhythms are biological oscillations that occur over a 24 hour 
period. They are maintained by an innate, genetically determined 
timekeeping system called the molecular circadian clockwork. Despite the 
physiological and clinical importance of the circadian clock, small molecule 
modulators of the core clock machinery remain largely unexplored. Thus I 
aimed to identify a synthetic molecule that influences the circadian clock 
molecular feedback loop via REV-ERBα activity. 
In Chapter 1, I aimed to identify novel small molecules that effectively 
and specifically modulate REV-ERBα activity and its physiological functions 




ROR/REV-ERB response elements (RORE)-driven luciferase reporter cell-
based assay (CBA). One compound, designated KK-S6, repressed the 
RORE-dependent transcriptional activity of the mBmal1 promoter and 
reduced endogenous BMAL1 protein expression. More importantly, KK-S6 
significantly altered the circadian oscillation amplitude of Bmal1 and Per2 
promoter activities in a dose-dependent manner, but barely affected the 
period length. In addition, KK-S6 strengthened transcriptional repression by 
REV-ERBα and effectively decreased mRNA expression of downstream 
genes of REV-ERBα that contained a RORE cis-element in their promoter. 
These findings suggest that KK-S6 could potentially be used as a treatment 
for clock-related disorders by increasing REV-ERBα activity. 
One of the novel physiological functions of circadian clock components is 
brain dopamine (DA) metabolism. Specifically, our laboratory previously 
determined that the circadian nuclear receptor, REV-ERBα, modulates 
tyrosine hydroxylase (TH) transcription through competition with nuclear 
receptor 1-related protein (Nurr1), a transcriptional activator of DA 
biosynthesis genes in the ventral tegmental area (VTA). Although 
considerable evidence suggests the prominent role of REV-ERBα in 
DAergic system, it is still unclear whether REV-ERBα can act on dopamine-
reward system.  Thus I examined the circadian action mediated by REV-
ERBα on dopamine-reward system. 
In Chapter 2, I investigated the impact of REV-ERBα on the dopamine 
reward system using a sucrose-seeking mouse model. Compulsive sucrose 




anxiety and depression levels throughout the circadian cycle. The FosB 
splice variant (∆FosB), a molecular marker of addiction, was induced in the 
nucleus accumbens (NAc) of sucrose-seeking mice at dusk. 
Simultaneously, Nurr1 expression was also greatly increased. During a 10-
day sucrose withdrawal period, Nurr1 expression returned to baseline 
levels and Rev-erbα was hyperexpressed; however, TH expression was 
unaltered. Moreover, sucrose reward managed circadian activity rhythms in 
the absence of light cue and can affect liver fat metabolism. These findings 
suggest that compulsive sucrose consumption can lead to abnormal 
emotional behaviors and gene expression alteration in the brain and liver, 
which are similar to symptoms experienced by binge-eating disorder (BED) 
patients. REV-ERBα may act as a controller, maintaining normal DA tone 
and homeostasis in response to DA transmission alterations following 
compulsive sucrose consumption. 
Overall, I successfully identified a novel synthetic molecule modulator of 
REV-ERBα and revealed the mechanism for REV-ERBα’s circadian action 
on the reward pathway. These findings suggest that disrupted reward 
system by sucrose overconsumption can be recovered by enhancing the 
REV-ERBα activity using its modulator. 
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1. Circadian timekeeping system 
 
1.1 Biological clock  
 
Most organisms from cyanobacteria to human live under the strong 
influence of light-dark and temperature cycles associated with day and 
night changes created by 24-hr rotation of the earth around its own axis. 
These organisms adapt to the regular environmental changes associated 
with the day-night cycle using a highly conserved internal timing system, 
known as the circadian clock. The word “circadian” comes from the Latin 
words “circa” and “diem”, meaning “about a day”. In all mammals, the 
suprachiasmatic nucleus (SCN) of the anterior hypothalamus functions as a 
master pacemaker, driving virtually all physiological intracellular clock 
systems (Figure 1). Light signals, which are perceived by photoreceptors in 
the intrinsically photosensitive ganglion cells of the retina, are transmitted 
electrically to SCN neurons through the retinohypothalamic tract (RHT). 
The SCN neurons then convert the electrical signals into chemical signals. 
These chemical signals reset the molecular oscillators in SCN neurons by 
modulating the molecular clock machinery. Finally, the SCN sends out 














Figure 1. Circadian rhythms and biological clock. The circadian rhythm 
is an endogenous biological process that produces an approximately 24-hr 
entrainable oscillation. It is controlled by a 'master clock,' which is a group 
of nerve cells in the suprachiasmatic nucleus (SCN). This master clock 
synchronizes all the various physiological clocks. Light is the primary cue 
influencing circadian rhythms and can induce or suppress the expression of 
genes controlling an organism's internal clock and physiological activities 

























govern rhythmic behavior. This phenomenon creates internal circadian 
rhythmicity and synchronizes activities, such as motivational behavior, food 
intake, energy metabolism, rest, and sleep. 
 
1.2 Molecular basis of circadian clock 
 
The internal timekeeping system is controlled by a series of gene 
regulatory mechanisms, known as the ‘biological molecular clock 
machinery’. In mammals, the circadian oscillator consists of the two 
interconnected positive and negative feedback loops that act at both the 
transcriptional and translational level (Takahashi. 2015) (Figure 2). Two 
rhythmically active transcription factors, CLOCK and BMAL1, are critical 
components of these feedback loops (Gustafson et al., 2015). In the 
primary feedback loop, CLOCK and BMAL1 form a heterodimer that 
positively regulates the transcription of several genes, including Periods 
(Per1, Per2, and Per3) and Cryptochromes (Cry1 and Cry2), by activating 
an E-box cis-element in their promoters. PERs and CRYs form large co-
repressor complexes. Once these complexes reach a critical concentration, 
they translocate into the nucleus and negatively regulate the transcription-
stimulation activity of CLOCK-BMAL1. This negative feedback reduces Cry 
and Per gene transcription and decreases their cellular concentration, 
which initiates a new PER/CRY accumulation cycle. In the secondary 
feedback loop, retinoic acid receptor-related orphan receptors (RORs) and 




related orphan receptor response elements (RORE) in the Bmal1 promoter 
region. REV-ERBα transcriptionally suppresses Bmal1 expression by 
recruiting the nuclear corepressor 1 (NCOR1)-histone deacetylase 3 
(HDAC3) corepressor complex, whereas RORα induces Bmal1 expression 
(Partch et al., 2014; Nangle et al., 2014). In addition to these transcriptional 
mechanisms, the core clock proteins are subjected to numerous well-
coordinated posttranslational modifications (PTM), such as phosphorylation, 
acetylation, and sumoylation. These PTMs are required to keep the clocks 
functioning normally. For example, PER phosphorylation by casein kinase 1 
modulates the oscillation period by affecting PER protein stability and 
activity (Sahar et al., 2010; St John et al., 2014). PER2 and BMAL1 can 
also be acetylated and deacetylated in a circadian fashion. Such an 





















Figure 2. Molecular architecture of the mammalian circadian clock. 
The cell-autonomous molecular clock in mammals is defined by two 
interlocking transcription-translation feedback loops. The core loop consists 
of four integral clock proteins: two activators, CLOCK and BMAL1, and two 
repressors, PER and CRY. PER and CRY proteins heterodimerize in the 
cytoplasm, translocate into the nucleus, and interact with the CLOCK-
BMAL1 heterodimer, inhibiting CLOCK-BMAL1 transcriptional activation. 
PER-CRY complexes are eventually degraded through ubiquitin (Ub)-
dependent pathways, which relieve CLOCK-BMAL1 repression and restart 
the cycle. This loop has 24-hr periodicity. The secondary loop is driven by 
ROR transcriptional activation and REV-ERB transcriptional repression. 
This loop induces rhythmic changes in Bmal1 transcription, decoupling 




























1.3 Central and peripheral oscillators 
 
The mammalian circadian system is organized hierarchically in tissues. 
Nearly all cells, including those in peripheral organs, have their own 
molecular circadian oscillator that coordinates rhythmic behaviors and 
physiology (Stratmann and Schibler, 2006). The first molecular clock 
machine was identified in the late 1990s, and the associated clock proteins 
were expressed in both the SCN and peripheral tissues. Balsalobre and 
colleagues demonstrated circadian gene expression in serum-shocked, 
cultured Rat-1 fibroblasts (Balsalobre et al., 1998). Similar oscillation 
patterns were observed in liver tissue explants (Yagita et al., 2001). These 
results provide compelling evidence supporting the presence of molecular 
circadian clocks in peripheral cell types. These molecular clocks, called 
peripheral clocks, are similar to those found in SCN neurons; however, 
studies have shown that they cannot maintain synchronicity independently. 
In mice with SCN ablations, peripheral organs had severely shifted 
endogenous circadian phases. By contrast, implantation of SCN neurons 
from wild-type mice into Cry1/2 double knockout mice restored rhythmic 
locomotor activity (Albus et al., 2002). Thus, SCN neurons act as a master 
clock and are necessary for peripheral clock synchronization and phase 
consistency in mammals. In addition to light, food and body temperature 






2. Circadian physiology and metabolism 
 
2.1 Circadian dysfunction in metabolism  
 
The periodicities of diverse physiological and behavioral outputs are 
dictated by the circadian timing system, which regulates sets of clock-
controlled genes (CCGs). This internal orchestration is essential to optimize 
metabolic responses and maintain homeostatic regulatory mechanisms 
(Levi and Schibler, 2007). CCG mutations can alter circadian cycle stability, 
amplitude, and period, which induce diverse physiological defects. 
Moreover, clock gene polymorphisms and behavior pattern de-
synchronization, caused by frequent air travel, chronic shift-work, or sleep 
restriction, can disrupt physiological circadian rhythms (Bechtold et al., 
2010). Recent evidence suggests that circadian system disruption 
contributes to clinical and pathological conditions, such as sleep disorders, 
cancer, mood disorders, and metabolic syndromes. Many metabolic 
processes, such as feeding behavior and glucose and lipid metabolism, 
exhibit coordinated circadian oscillation. Numerous rhythmically expressed 
circadian transcripts participate heavily in metabolic pathways and are 
involved in metabolic control. For example, circadian locomotor output 
cycles kaput (Clock)Δ19/Δ19 mutant mice suffer from impaired glucose and fat 
metabolism in liver and become obese. The CLOCKΔ19 mutation has been 
implicated in the development of glucose intolerance and metabolic 




2015). This mutation can also blunt Per2 transcript levels in kidney and 
heart. In contrast, BMAL1-deficient mice suffer from hypoglycemia and 
display altered circadian expression of glucose metabolic genes in liver. 
BMAL1-deficient embryonic fibroblasts (MEFs) cannot differentiate into 
adipocytes; however, this differentiation defect is restored when cells are 
transfected with BMAL1. REV-ERBs overexpressed in liver cells markedly 
dampened circadian expression of the hepatic transcriptome (Duez and 
Staels, 2009). These results suggest that clock-related gene mutations and 
polymorphisms are heavily involved with metabolic syndromes in human.  
 
2.2 Circadian disturbance and behavioral abnormality 
 
Defective clock gene expression leads to behavioral abnormalities similar 
to those observed in patients with psychiatric disorders and 
neurodegenerative diseases. Patients suffering from neuropsychiatric 
disorders, including major depressive disorder (MDD), schizophrenia, and 
substance abuse, often present with weak biological rhythm regulation. 
Recent rodent studies showed that clock gene manipulation severely 
affects emotional behaviors. ClockΔ19/Δ19 mice displayed increased drug-
seeking, hyperactive behavior, and DA neuron excitability in the mesolimbic 
pathway, a key brain reward region compared with wild-type mice. Per1 
gene mutation decreased drug sensitization, whereas Per2 gene mutation 
led to drug hypersensitization (Abarca et al., 2002). Other circadian clock 




Bmal1 or Per2 in brain exhibit mania-like behavior, and Cry1/Cry2 double 
knockout mice exhibit abnormal anxiety-like behavior and cocaine 
sensitization (Bundel et al., 2013). Moreover, Rev-erbα deletion in the 
ventral midbrain caused emotional instability, mimicking symptoms of 
bipolar disorder (BPD) (Chung et al., 2014). These results emphasize the 
molecular links between circadian timing and mood disorders. 
 
2.3 Pharmacological modification of the molecular clock 
 
Because circadian clock proteins play an important role in regulating 
metabolism and behavior, many researchers focused on developing 
synthetic molecules that effectively modulate their activity. These synthetic 
molecules could potentially be used to treat various physiological 
dysfunctions (Figure 3). For example, the mood stabilizer lithium is 
commonly used to treat depressive patients. Lithium lengthens the 
circadian period by inducing phosphorylation of PER2 and REV-ERBα. 
Kinases, such as glycogen synthase kinase 3ß (GSK-3β) and the casein 
kinases 1ε and δ (CK1ε/δ), may serve as a pharmacological entry points to 
alter the circadian clock. Treatment with the CKIδ inhibitor, PF-670462, 
lengthened circadian period and increased nuclear retention of PER2 
(Meng et al., 2010). Selective inhibition of CK1ε by PF-4800567 alters 
circadian clock period (Walton et al. 2009). Recently, large-scale chemical 
screening identified a casein kinase inhibitor, named longdaysin. CKIα 




degradation (Hirota et al., 2010). RORs and REV-ERBs are also potential 
pharmacological targets for modulating the circadian clock. For example, 
heme influences REV-ERB transcriptional potential. The synthetic agonist 
GSK4112 competes with heme, inhibiting REV-ERB activity. Thus, 
GSK4112 can be used to probe REV-ERB function (Grant et al., 2010). 
Recently, a synthetic REV-ERB antagonist (SR8278) and two agonists 
(SR9009 and SR9011) were identified (Kojetin et al., 2011; Solt et al., 2012). 
Intraperitoneal administration of SR9009 or SR9011 produced reasonable 
plasma exposure in vivo. Several ROR modulators have been developed. 
The small molecule R1078 is an RORα and RORγ agonist, and another 
molecule, SR3335, appears to be a RORα selective inverse agonist. Small 
molecule activators of CRY have also been identified. For example, the 
CRY activator, KL001, lengthened the circadian period by preventing CRY 
degradation (Hirota et al. 2012). Taken together, synthetic modulators are 
capable of regulating the circadian clock at the molecular level and could 
potentially relieve the symptoms of clock-related diseases. 
 
2.4 Molecular mechanism of REV-ERBα action 
 
REV-ERBα, which is encoded by the NR1D1 gene, was one of the first 
orphan nuclear receptors (NR) discovered (Yin et al., 2010). In the 
circadian machinery, REV-ERBα contributes to the secondary feedback 
loop by repressing transcription of the core clock gene, Bmal1. As 












Figure 3. Small molecule modifiers of circadian clocks. In the 
mammalian circadian clock system, external signals are transmitted via 
molecular oscillator input pathways. These pathways consist of interlocking 
feedback loops. Most synthetic small molecule modifiers allosterically alter 
the protein in a reversible manner. They were identified based on direct 
interactions with their associated clock proteins or kinases, such as casein 
































NCoR1-HDAC3 complex to the RORE promoter during circadian night, 
leading to rhythmic expression of the Bmal1 gene. With respect to PTMs, 
the amino terminus of REV-ERBα can be phosphorylated at serine 55 and 
serine 59 by GSK-3β, which stabilizes the protein. REV-ERBα stabilization 
leads to rapid proteasomal degradation, reducing the amount of REV-ERBα 
available to repress transcription of downstream targets. Thus, GSK-3β 
mediated stabilization of REV-ERBα appears to be an important event for 
circadian rhythm initiation, maintenance, and synchronization. Interestingly, 
certain alleles in Rev-erbα and GSK3B loci have additive effects on lithium 
responsiveness among BPD patients (Yin et al., 2006). Because lithium is a 
potent GSK-3β inhibitor, control of REV-ERBα is considered to be a 
biological target for BPD therapy. 
REV-ERBα–NCoR1 binding is stabilized by the endogenous REV-ERBα 
ligand, heme (Yin et al., 2007). Two groups independently determined that 
heme reversibly binds histidine 602 (H602) in the REV-ERBα ligand-binding 
domain (LBD). Heme can be displaced by a molar excess of heme analogs, 
which subsequently modulates REV-ERBα’s interaction with the 
corepressor complex. This discovery means that REV-ERBα is 
misclassified as an orphan nuclear receptor. Recent studies, described 
above, support using synthetic modulators to target REV-ERBα for 
therapeutic purposes. 
 





The first synthetic REV-ERB-targeting molecule was GSK4112, identified 
using an REV-ERB LBD/NCoR1 fluorescence resonance energy transfer 
(FRET) assay (Grant et al., 2010). GSK4112 increases recruitment of 
NCoR1 to the Bmal1 promoter and induces recruitment of HDAC3 to the 
G6Pase promoter. GSK4112 also significantly represses the transcription 
levels of Bmal1 and several marker genes of hepatic gluconeogenesis, 
such as G6pase, phosphoenolpyruvate carboxykinase (Pepck), and Pgc1α, 
in hepatocytes. However, this compound is not a suitable probe for the 
REV-ERBs activity in in vivo studies because of its weak efficacy. The next-
generation REV-ERBs modulators are SR9009 and SR9011 (Solt et al., 
2012). Both of these compounds are three- to four-fold more potent and 
efficacious than GSK4112 due to several modifications that improved the 
pharmacokinetic properties. Administration of either compound in mice 
resulted in loss of wheel running activity and affected the circadian 
expression of CCGs in the hypothalamus. Notably, weight loss and 
decreased total cholesterol was observed in obese mice without altering 
locomotor activity or food intake. Mice treated with either of the REV-ERB 
agonists exhibited alterations in sleep architecture, anxiety levels, and 
reward sensitivity. In addition, SR9009 affected atherosclerosis in LDL 
receptor-deficient mice (Sitaula et al., 2015). Together, SR9009 and 
SR9011 substantially affect circadian physiology through pharmacological 
activation of REV-ERBs. Four additional REV-ERBs agonists have been 
developed recently, and studies indicate that they are bioavailable and have 




On the other hand, only one REV-ERBs antagonist, SR8278, has been 
identified to date, and it has been shown to reverse the agonist activity of 
GSK4112 in hepatic gluconeogenesis (Kojetin et al., 2011) Treatment with 
SR8278 activates the connexin43 promoter by interacting with the 
transcription factor SP1 in a ligand-independent manner that does not 
involve the REV-ERBα LBD. These potent synthetic modulators could be 
used as chemical tools to probe the REV-ERBs’ various physiological 
functions. 
 
2.6 Physiological importance of REV-ERBα 
 
REV-ERBα has widespread functions throughout the body and allows an 
organism to respond to unexpected physiological changes. REV-ERBα is 
highly expressed in metabolic tissues, including peripheral metabolic 
tissues (e.g., liver, adipose tissue, skeletal muscle, and pancreas) and the 
brain. Numerous studies have shown that REV-ERBα links the circadian 
clock system and metabolism in mammals. Loss-of-function and genome-
wide cistromic profiling revealed that REV-ERBα expression has a more 
profound impact than previously suspected. More than 90% of the 
approximately 900 genes expressed in the liver became arrhythmic in a 
Rev-erb knockout mouse, compared to the wild-type mouse. Knocking out 
Rev-erbα/β specifically in the liver resulted in mice with severe circadian-
associated disruption of liver metabolism (Cho et al., 2012). For example, 




due to a high-fat diet (HFD) (Ruano et al., 2014). Rev-erbα-deficient mice 
suffer from severe hepatic steatosis and irregular atherosclerosis 
development. Loss-of-function studies, both in vitro and in vivo, 
demonstrate that REV-ERBs participate in hepatic lipid and glucose 
metabolism. Pharmacological activation of REV-ERBα leads to acceleration 
of adipogenesis, loss of fat mass, and increased energy expenditure 
(Kumar et al., 2010). REV-ERBα positively modulates very-low-density 
lipoprotein (VLDL) triglyceride levels in the lipid metabolic pathway and also 
modulates the expression of gluconeogenesis-related genes, such as 
carboxykinase (PCK) and glucose‑6‑phosphatase (G6PC) (Ramakrishnan 
et al., 2009). REV-ERBα can affect the gene networks that control oxidative 
capacity and mitochondrial contents of skeletal muscle in mice and 
increase exercise endurance (Woldt et al., 2013). REV-ERBα is also 
considered to be a key regulator of the oxidative capacity of skeletal muscle 
and mitochondrial biogenesis (Woldt et al., 2013). Heme concentration 
increases during adipogenesis, and repression of heme biosynthesis 
inhibits adipogenesis (Laitinen et al., 2005). Overexpressed REV-ERBs 
reduce intracellular heme levels by directly modulating peroxisome 
proliferator-activated receptor γ co-activator 1α (PGC-1α). Recent studies 
showed that hepatic phosphatidylcholine is modulated by the circadian 
clock through a BMAL1-REV-ERBα-choline kinase α (Chkα) axis (Gréchez-
Cassiau et al., 2015). Overall, there is substantial evidence suggesting that 
REV-ERBα is a crucial component that links the circadian system to the 




REV-ERBα dysfunction alters normal physiological processes and leads 
to neuropsychiatric disorders, including anxiety, bipolar disorder, and 
schizophrenia. These disorders frequently involve impaired midbrain 
dopaminergic function, which affects the brain reward system. REV-ERBs 
affect sleep-wake patterns and sleep architecture by altering cell energetics. 
Rev-erbα-deficient mice show reduced depressive behavior, increased risk-
taking, hyperactivity, and unusual aggression toward intruder mice without 
daily variation (Chung et al., 2014). Moreover, depleted REV-ERBα 
suppresses reward-seeking behaviors, such as cocaine-induced condition 
place preference (CPP) (Banerjee et al., 2014). Recent findings report that 
REV-ERBα can control dopaminergic function and mood-related behavior 
by modulating DA biosynthesis through rhythmic expression of tyrosine 
hydroxylase (TH) in midbrain dopaminergic neurons. These results indicate 
that REV-ERBα expressed in the midbrain is involved in mood behavior via 
DA metabolism. 
 
3. Reward system 
 
3.1 Dopaminergic pathway  
 
Dopamine (DA) is one of the catecholaminergic neurotransmitters in the 
central nervous system. While dopaminergic (DAergic) distribution 
represents less than 1% of the total neuronal population of the brain, DA 




been identified in the mammalian brain (Figure 4): the nigrostriatal pathway, 
mesolimbic pathway, mesocortical pathway, and tuberoinfundibular 
pathway (Smith and Kieval, 2000). These neural pathways are heavily 
involved in a myriad of affective disorders (such as schizophrenia, 
hyperactivity, bipolar disorder, and addiction) and various vital central 
nervous system functions, including feeding, reward, motivational behavior, 
and synaptic plasticity modifications associated with learning and memory. 
Because DA has pivotal roles in various physiological functions, it is not 
surprising that multiple human disorders have been connected to DAergic 
dysfunctions. 
 
3.2 The mesocorticolimbic DA pathway and its rewarding system  
 
The mesolimbic and mesocortical DAergic pathway originates in the ventral 
tegmental area (VTA) and primarily projects to the nucleus accumbens 
(NAc) and prefrontal cortex (PFC), which have pivotal roles in processing 
reward-related stimuli and emotional behaviors. These areas combined are 
referred to as the “mesocorticolimbic system.” Reward signals are induced 
when DA is released in the shell, a subregion of the NAc, where it mimics 
phasic DA neuronal firing. Reward is an important emotion that supports 
fundamental activities, such as drinking, eating, and reproduction. Over the 
past 40 years, many psychologists have tried to develop and refine the 
animal models of addiction used for reward studies (Arias-Carrión et al., 













Figure 4. Dopaminergic pathway. Four major pathways in dopaminergic 
system: the nigrostriatal pathway, mesolimbic pathway, mesocortical 
pathway, and tuberoinfundibular pathway. These neural pathways are 
heavily involved in various vital central nervous system functions, including 
feeding, reward, motivational behavior, and synaptic plasticity modifications 






























substance-induced abnormal rewarding activity. Several rodent models 
mimic human addictions, including alcohol, nicotine, drug, food, and sugar 
addiction. Diverse findings support the hypothesis that repetitive substance 
use enhances midbrain DA function and can wholly reverse the DA 
metabolism in the brain, particularly in the NAc region (Volkow and Morales, 
2015). Reinforced desire for addictive substances eventually causes 
repeated over-consumption and subsequent hyper-extracellular DA 
concentrations. This increased extracellular DA stimulates dopamine 
receptor 3 (D3R), which facilitate transmission via the dopamine receptor 1 
(D1R) direct pathway. Stimulating this pathway enhances cravings and the 
drive to continuously take the substance (Luo et al., 2011). In addition, DA 
transporters participate in the removal of DA from synapses, which causes 
addiction-induced hyper-extracellular DA. 
 
3.3 DA metabolism and molecular clock machinery 
 
As stated above, addiction is caused by reward dysfunction. In animal 
addiction models, locomotor sensitization and drug self administration vary 
based on day-night cycles. This variation indicates an interaction between 
the circadian clock and reward system. Several studies demonstrated that 
Per1 and Per2 genes affect cocaine-induced sensitization and reward in an 
opposite manner (Carolina et al., 2002). Per1 enhances cocaine 
sensitization and reward, whereas Per2 attenuates them. Moreover, Per1 












Figure 5. Function of REV-ERBα in DA-biosynthesis in midbrain VTA. 
Reward-related behavioral rhythms are associated with rhythmic neural 
activity and dopaminergic signaling in the mesocorticolimbic pathways. The 
mesocorticolimbic pathway originates in the VTA and projects into the 
nucleus accumbens (NAc) and frontal cortex (PFC). In the VTA, REV-ERBα 
contributes to transcriptional control of TH via competition with nuclear 































al., 2013). By contrast, these genes are significantly reduced in the NAc 
under stress, leading to hyper-anxiety. Circadian clockwork components 
are proposed to control several key DA-regulating genes. For example, the 
Per2 gene helps lower the transcription activity of monoamine oxidase A 
(MAOA), which accelerates DA degradation in the striatum and contributes 
to increased dopamine levels (Hampp et al., 2008). The MAOA promoter is 
modulated by several clock components, including BMAL1 and neuronal 
PAS domain protein 2 (NPAS2). CLOCK protein is also involved in 
regulating dopaminergic transmission in the brain’s reward circuit. Clock-
deficient mice display increased hyperactive behavior, drug reward, and 
dopamine neuron excitability in the VTA (McClung et al., 2005). 
Furthermore, TH is negatively regulated by CLOCK protein. Recent studies 
revealed that REV-ERBα competes with NURR1, a DA biosynthesis 
activator, to regulate TH gene transcription levels, which applies circadian 
level regulation of the dopaminergic system (Chung et al., 2014) (Figure 5). 
Overall, evidence supports the existence of interactions between circadian 
rhythms and dopaminergic transmission, which could provide valuable 











Molecular clock machinery is present in all mammalian tissues and 
functions as an essential component of physiological homeostasis. 
Specifically, REV-ERBα participates in the network of interlocking circadian 
feedback loops, various metabolic processes, and the dopaminergic 
pathway. Many researchers have attempted to identify non-porphyrin 
synthetic modifiers that modulate REV-ERBα activity. While there is 
considerable evidence suggesting a prominent role of REV-ERBα in 
dopaminergic system, it is still unclear whether the REV-ERBα acts on 
dopamine-reward system. Thus, I addressed two issues: 
 
(1) To identify a novel synthetic REV-ERBα modulator that can regulate 
the REV-ERBα-related physiological functions using a cell-based 
assay (CBA) system, and 
 
(2) To examine the REV-ERBα circadian action on dopamine-reward 















Identification of a novel circadian clock 
modulator acting through a ROR/REV-ERB-












REV-ERBα (NR1D1) is a member of the nuclear receptor superfamily of 
transcription factors, which regulate a wide range of biological processes. 
In the mammalian circadian system, REV-ERBα regulates the 
transcriptional repression of Bmal1 through the ROR/REV-ERB-response 
element (RORE). To identify novel modulators of REV-ERBα, a druggable 
compound library of small synthetic molecules was screened using a cell-
based assay with a RORE-driven luciferase reporter. One compound, 
designated as KK-S6, repressed RORE-mediated transcriptional activity 
but not activity of a mutated RORE. Moreover, KK-S6 negatively regulated 
expression levels of Bmal1 mRNA and protein, but did not affect 
transcriptional activity of Bmal1 in mouse embryonic fibroblast cells (MEFs) 
derived from Rev-erbα knock-out mice. KK-S6 significantly altered the 
amplitude of circadian oscillations of RORE and/or Per2 dose-dependently 
in vitro and ex vivo, but did not affect the period length. Furthermore, it 
decreased levels of mRNA expression in genes acting downstream of REV-
ERBα, which contained RORE in their promoter regions, such as Pai-1 and 
Citrate synthase. Since KK-S6 is structurally different from previously 
known synthetic REV-ERBα agonists, present results indicate that KK-S6 
functions as a novel clock modulator through a RORE-mediated 


































Circadian rhythms with periods of about 24 hours are found in most 
biological processes in mammals. The circadian timing system is organized 
hierarchically into multiple oscillator networks. Co-ordination of the 
circadian system across the whole body involves regulation of signals 
emanating from the suprachiasmatic nuclei (SCN; a central, master 
pacemaker in the anterior hypothalamus), subsidiary clocks in extra-SCN 
brain regions and peripheral organs, which regulate physiological and 
behavioral outputs (Dibner et al., 2010; Mohawk et al., 2012; Welsh et al., 
2010).  
Most cells share a circadian clock timing system consisting of two core 
components: circadian locomotor output cycles kaput (CLOCK) and brain-
muscle-ARNT-like protein 1 (BMAL1). The molecular clock machinery 
consists of two interlocked positive/negative feedback loops. In the core 
clock loop, CLOCK and BMAL1 form heterodimers that positively regulate 
the transcription of period (Per1, Per2, and Per3) and cryptochrome (Cry1 
and Cry2) genes through activating a cis-element, the E-box, in their 
promoters. PERs and CRYs can dimerize and are phosphorylated by 
casein kinase (Gustafson et al., 2015). This complex translocates into the 
nucleus where it negatively regulates Clock and Bmal1 transcription. In 
addition, the circadian nuclear receptors, RORα and REV-ERBα, bind to 




region. REV-ERBα and RORα compete for the same binding motif (RORE); 
however, REV-ERBα suppresses Bmal1 transcription whereas RORα 
induces it, forming a stabilizing loop (Partch et al., 2014; Nangle et al., 
2014). Such an operating system is closely involved in the fine-tuning of 
circadian oscillations. 
Along with the transcriptional regulation underpinning the molecular 
makeup of the clock machinery, post-translational modification processes, 
involving the phosphorylation (Sahar et al., 2010), ubiquitination, 
sumoylation (Lee et al., 2008), protein stability, signal transduction 
(Hirayama et al., 2007) and subcellular trafficking (St John et al., 2014) of 
clock proteins, have been extensively studied. Another avenue is the 
characterization of orphan circadian nuclear receptors. Since the mid-
1990s, studies of both RORα and REV-ERBα have been attempted to 
identify their endogenous ligands or alternatively to develop synthetic small 
molecules capable of acting as ligands. In the early 2000s, synthetic 
modulators of RORα were frequently reported and used in physiological 
and pharmacological studies of circadian regulation, and also in 
investigations of metabolic homeostasis (Kumar et al., 2010; Wang et al., 
2010). REV-ERBs were thought to be orphan nuclear receptors until the 
porphyrin heme was identified as their physiological ligand (Yin et al., 2007). 
Heme, however, could not be used as a chemical probe for REV-ERBα 
because of its toxicity at higher concentrations and non-specific interactions 
with other cellular targets. Many researchers therefore attempted to identify 




an initial non-porphyrin ligand of REV-ERBα, was discovered using a 
fluorescence resonance energy transfer (FRET) assay involving the ligand-
binding domain (LBD) of REV-ERBα and the interacting domain of NCOR1 
(Grant et al., 2010). Burris and his colleagues later found that the synthetic 
REV-ERBs modulators, SR9011 and SR8278, altered both central and 
peripheral circadian clockwork in vitro and in vivo (Solt et al., 2012; Kojetin 
et al., 2011).  
REV-ERBα plays important roles in regulating metabolic homeostasis 
and energy balance (Ripperger et al., 2012). Loss-of-function and genome-
wide cistromic profiling revealed that REV-ERBα had more profound 
functions than previously suspected. More than 90% of the approximately 
900 genes expressed in the liver became arrhythmic in a Rev-erbs knock-
out mouse, compared to the wild-type mouse. Knocking out Rev-erbα/β 
specifically in the liver resulted in mice with severe circadian-associated 
disruption of liver metabolism (Cho et al., 2012), and pharmacological 
activation of REV-ERBα leads to acceleration of adipogenesis, loss of fat 
mass and increased energy expenditure (Kumar et al., 2010). REV-ERBα 
can also modulate gene networks controlling oxidative capacity and 
mitochondrial contents in skeletal muscle in mice with increased exercise 
endurance (Woldt et al., 2013). Recent studies indicate that REV-ERBs 
modulate sleep and emotional behaviors (Banerjee et al., 2014). We 
recently found a pivotal role for REV-ERBα in the ventral midbrain (VMB) in 
the regulation of tyrosine hydroxylase (TH) gene transcription, thereby 




Using a cell-based screening method based on a RORE reporter system, 
I identified a novel synthetic compound that modulates clock activity (REV-
ERBα), and validated its functional significance in vitro and ex vivo. 
Although several synthetic compounds modulating REV-ERBα activity have 
been identified since my study began, as mentioned above (Grant et al., 
2010; Solt et al., 2012), this novel compound has a chemically distinct 
















MATERIALS AND METHODS 
 
Plasmid constructions. A 2×RORE::Luc reporter plasmid was prepared 
by inserting a fragment containing two copies of RORE (171bp; -106 to +65 
from the transcriptional start site of the Bmal1 gene) into the pGL3-
promoter vector (Promega) using the XhoI and NheI restriction sites. The 
mutated RORE reporter constructs (mRORE1, mRORE2 and mRORE1/2) 
were generated from 2×RORE::Luc using site-directed mutagenesis with 
the following primers: RORE1 mutant up: 5’-CGGATTGGTCGG 
AAAGTACATTAGTGGTGCGA CATTTAG-3’; RORE1 mutant dn: 5’-
CTAAATGTCGCACCACTAATGTACTTTCCGACCAATCCG-3’; RORE2 
mutant up: 5’-GGAAGGCAGAAAGTACATCAGGGACGGAGGC-3’; RORE2 
mutant dn: 5’-GCCTCCGTCCCTGATGTACTTTCTGCCTTCC-3’. The PCR 
products were digested with DpnI for 1 hour and then transformed into 
DH5α competent cells. Colonies were picked and grown in LB media (plus 
ampicillin) for 12 hours. Plasmid DNA was isolated using the Dokdo-Prep™ 
kit (Elpis Biotech). Each mutated 2×RORE::Luc reporter construct was 
confirmed by sequencing.  
 
Luciferase assay. Each of the luciferase reporter and expression vectors 
were transfected together with 400 ng of a Renilla luciferase promoter 
construct (pRL-basic; an internal control for transfection efficiency) into 




cell extracts were prepared by incubation in 0.1 ml of 1× lysis buffer 
(Promega) for 20 minutes at room temperature. Firefly and Renilla 
luciferase activities were measured using the Dual Luciferase Reporter 
Assay Kit (Promega). Reporter-driven firefly luciferase activities were 
normalized on Renilla luciferase levels (Cheon et al., 2013).  
 
Cell-based assay screening. A small, druggable, scaffold-based library 
containing 1128 compounds was obtained from the College of Pharmacy, 
Seoul National University. Each compound was dissolved in DMSO and 
used at the indicated dosage. Compounds were screened using a cell-
based assay. NIH3T3 cells were seeded in 24-well plates and transfected 
using Metafectine easy (Biontex) with two plasmids containing the 
2×RORE::Luc reporter and pRL-basic constructs. Transfected cells were 
treated with vehicle DMSO or chemical compounds and incubated for 24 
hours. Luciferase assays were performed as described previously (Chun et 
al., 2014). Changes in luciferase expression were converted to a logarithm 
scale and the mean ± standard error (SE) were calculated and regarded as 
an index for selection of the primary screening process. 
 
Stable cell lines and cell culture. Stably transformed cells were 
generated by two methods. For transfection experiments, NIH3T3 cells 
were transfected with the 2×RORE::Luc wild-type reporter or a mutated 
2×RORE::Luc reporter (mRORE1, mRORE2, and mRORE1/2) and a 




the standard medium was replaced with medium containing G-418 (Gibco) 
at a final concentration of 400 μg/ml. After 3 weeks of G418 selective 
pressure to produce stable cell lines (typically every three passages), the 
G418 concentration was gradually reduced to 100 μg/ml. For viral 
transformation, the 2×RORE::Luc reporter was inserted into an ID retroviral 
vector (provided by Prof. Sunyoung Kim, Department of Biological Sciences, 
Seoul National University) using the MluI, NcoI and XhoI restriction sites. 
The ID vector containing 2×RORE::Luc was transfected into HEK293T cells, 
together with pVM-GP and amphotropic env expressing pVM-AE, using 
Lipofectamine Plus reagent (Invitrogen). Supernatants were collected 48 
hours after transfection, filtered through a 0.45 μm filter and used for the 
transduction of NIH3T3 cells. To measure luciferase activity, stably 
transformed cells were seeded in a 35 mm dish and monitored for real-time 
bioluminescence using a wheel-type luminometer (AB-2550 Kronos-Dio; 
ATTO). NIH3T3 and HepG2 cells were maintained in Dulbecco’s modified 
Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS) 
and 1% penicillin/streptomycin (Invitrogen) at 37°C under 5% CO2. Each 
stable cell line was maintained in medium (DMEM supplemented with 10% 
FBS and 2% penicillin/ streptomycin) containing G-418 (100 μg/ml). 
 
Mammalian one-hybrid assay. In the mammalian one-hybrid assay, a 
DNA sequence of interest is placed upstream of a reporter gene (upstream-
activation sequence; UAS). If the protein is able to interact with the UAS, 




ERBα was cloned into a vector expressing protein fused to a DNA-binding 
domain (Solt et al., 2012). The LBD of human REV-ERBα (coding for amino 
acids 418 to 611) was amplified from a full-length human EGFP-Rev-erbα 
plasmid clone using PCR. PCR products were initially cloned into the 
pGEM-T Easy vector (Promega) and confirmed using chain termination 
sequencing. Subsequently, the amplified LBD of Rev-erbα was inserted into 
the pM vector (Clontech) using the BamHI and HindIII restriction sites. 
 
Explant culture of the SCN. Neonatal pubs (7 days post-birth) produced 
by Per2::Luc knock-in mice, in which a firefly luciferase gene is fused in-
frame to the 3’ end of the endogenous Per2 gene, were sacrificed and their 
brains quickly removed (Yoo et al., 2004). Coronal sections (300 μm 
thickness) of brains were cut using a vibratome and the SCN were 
dissected out. Brain slices containing the SCN were maintained on culture 
insert membrane (Millipore) dipped into culture medium (50% minimum 
essential medium, 2% Gey’s balanced salt solution, 25% horse serum, 36 
mM glucose and 100 units/ml aerosolized antibiotics) in incubators at 37°C 
under 5% CO2. The SCN slices were cultivated for 2 weeks before being 
used in experiments. 
 
Real-time bioluminescence recording. Stably transformed cells 
expressing 2×RORE::Luc or Per2::Luc were seeded in 35 mm dishes. Cell 
cultures were synchronized with 1 μM dexamethasone (DEX) for 2 hours 




medium (DMEM supplemented with 10% FBS, 2% penicillin/streptomycin) 
containing vehicle (DMSO) or chemical compounds at the indicated 
concentrations. Brain slices containing SCN from Per2::Luc knock-in mice 
were maintained in a sealed 35 mm dish with 1 ml of the culture medium 
(50% minimum essential medium, 25% Gey’s balanced salt solution, 25% 
horse serum, 36 mM glucose, and 100 units/ml aerosolized antibiotics) 
containing 0.3 mM D-luciferin (Promega) in a chamber at 37°C. 
Bioluminescence levels from cells were recorded for 1 minute at intervals of 
9 minutes, and from SCN slices for 2 minutes at intervals of 18 minutes 
using a dish-type wheeled luminometer (AB-2550 Kronos-Dio; ATTO). Each 
dish containing samples was maintained continuously and the 
luminescence levels were recorded for at least 3 days (Koo et al., Epub 
ahead of print).  
 
RNA isolation and real-time quantitative PCR. HepG2 cells were 
harvested and washed with phosphate buffered saline (1× PBS). Total RNA 
was isolated using the single-step acid guanidinium thiocyanate-phenol-
chloroform method (Son et al., 2008) and 3 μg RNA reverse-transcribed 
using Moloney murine leukemia virus reverse transcriptase (M-MLV reverse 
transcriptase) (Promega). Real-time PCR was carried out in the presence 
of SYBR Green I (Sigma). Gene expression levels were normalized against 
expression of TATA box-binding protein (Tbp). Primer sequences used in 
real-time RT-PCR were as follows: Bmal1 up: 5’-TTA AGA GGT GCC ACC 




AAG ACT CCC TTC CCC GAC TC-3’; Pai-1 dn: 5’-GGG CGT GGT GAA 
CTC AGT ATA G-3’; citrate synthase up: 5’-TAG TGC TTC CTC CAC GAA 
TTT G’-3’, citrate synthase dn: 5’-CCA CCA TAC ATC ATG TCC ACA G-’3’; 
Tbp up: 5’-CGG CTG TTT AAC TTC GCT TC-3’; Tbp dn: 5’-TTC TTG GCA 
AAC CAG AAA CC-3’. Primer sequence data were based on previous 
reports (Wang et al., 2006; Crumbley et al., 2012). The reactions were first 
incubated at 94°C for 10 minutes, followed by 50 cycles at 95°C for 15 
seconds, 62°C for 30 seconds and 72°C for 30 seconds. 
 
Western blot analysis. Immunoblot analyses were performed on 8% 
sodium dodecylsulfate polyacrylamide gels. Whole-cell extracts were 
loaded on sodium dodecylsulfate (SDS)-polyacrylamide gels and 
transferred to polyvinylidene difluoride (PVDF) membranes (Millipore) in a 
Bio-Rad Trans-Blot electrophoresis apparatus using Towbin’s buffer (25 mM 
Tris, pH 8.3, 192 mM glycine and 20% methanol). The blots were blocked 
in 1× Tris-buffered saline (TBS; 150 mM NaCl, 10 mM Tris, pH 7.6 and 2 
mM MgCl2) containing 0.3% Tween-20 with 10% skimmed milk and 
incubated with primary antibody at room temperature for 90 minutes. They 
were then washed four times with 1× TBS/0.3% Tween-20. Antibody 
binding was subsequently detected by incubation with secondary 
antibodies linked to horseradish peroxidase (Jackson Immuno Research 
Laboratories). Expression levels were visualized using an ECL detection kit 
(Pierce). Anti-BMAL1 and anti-α-actin (s.c.-56459; Santa Cruz) were 




rabbits and affinity-purified, as described previously (Kwon et al., 2006).  
 
Statistical analysis. All of the individual co-transfection experiments were 
performed in 24-well plates and each experiment was repeated at least 
three times. Results from the co-transfection experiments were normalized 
against activity of a Renilla luciferase control. Data were analyzed using 
one-way analysis of variance (ANOVA) with Tukey post-hoc tests using 
GraphPad Prism software. P-values of less than 0.05 were considered to 





















Cell-based screening to identify synthetic compounds modulating the 
RORE activity 
 
To identify novel circadian clock modulator(s) responsible for binding the 
RORE cis-element, I screened compounds using a cell-based assay 
utilizing the RORE-mediated luciferase reporter system. The reporter 
contained two copies of RORE from the proximal region of the Bmal1 
promoter (Fig. 6A). When induced by dexamethasone, cultured NIH3T3 
cells transfected with this reporter displayed a circadian oscillation similar to 
that of Bmal1 (Fig. 6B). Transient expression of RORα induced reporter 
activity whereas that of REV-ERBα repressed it. Repression of luciferase 
activity by REV-ERBα was up-regulated by increases in levels of RORα, 
which competes with REV-ERBα for the RORE binding site (Fig. 6C). In an 
initial attempt to identify circadian modulator(s), I conducted a screen of 
1128 druggable compounds (20 μM) which were previously described 
uncharacterized chemical library (Chun et al., 2014) using cells expressing 
the 2×RORE::Luc reporter. When the cut-off point for accepting an effect 
was set to > 1.5-fold change from the control value (1.0), a quarter of the 
compounds screened produced a significant change in RORE-mediated 
luciferase activity and the rest had no effect (Fig. 7). Next, I classified the 




the primary screen into 14 groups (named A-N) based on their structural 
similarities. Intriguingly, only members of group B (designated as KK-S) 
had a uni-repressive effect on RORE activity (Fig. 8A). Even though ten 
compounds in this group were not strong enough to repress reporter 
activity, on the basis of their structural formulae, I estimated that the 
common moiety (structural analogs) of ten compounds (open bar) found 
among all 68 compounds in the KK-S family was responsible for modulating 
the reporter’s activity (Fig. 8B). The ten chromene-truncated compounds 
shared a common structure and moiety (Fig. 8C). I further investigated the 
dose-response relationships of ten compounds in the KK-S subfamily 
(named KK-S1-10) at concentrations ranging from 0.02 to 20 μM. All except 
KK-S5 produced a slight decrease in a dose-dependent manner in 
luciferase activity driven by the RORE (Fig. 9).  
 
Validation of the RORE sequence specificity 
 
I further investigated whether the presence of two ROREs was essential 
for each of the ten candidate compounds using reporters containing 
mutated ROREs. A GG/CA mutation in RORE1 and/or RORE2, produced 
by site-directed mutagenesis, completely abrogated the effects of REV-
ERBα or RORα on reporter activity and circadian oscillation profiles (Fig. 
10). Based on the dose-response curves, in which nine out of ten 
compounds from the KK-S subfamily repressed activity of the 




compounds produced RORE sequence-specific activity. When the effect of 
these compounds on the wild-type and mutated RORE constructs were 
compared, only KK-S6 treatment resulted in RORE-specific repression of 
luciferase activity (Fig. 11A). KK-S6 is quite flexible and consists of two 
aromatic systems linked by an ethylene bridge. The R group of KK-S6 
contains a unique alkyne (triple bond) unit which can display a π-π 
interaction as well as a hydrophobic interaction (Fig. 11B). Furthermore, I 
did not observe any change in repression of promoter activity in response 
to KK-S6 when the mRORE1 or mRORE2 constructs were tested (Fig. 
11C). It therefore appears that only the effects of KK-S6 on reporter activity 
are specific to the RORE sequence. 
 
KK-S6 affects cellular oscillation in vitro and ex vivo 
 
To explore the functional relevance of the regulation of circadian 
oscillations by KK-S6, I examined temporal oscillations driven by RORE or 
the Per2 promoter. Stable cell cultures harboring either 2×RORE::Luc or 
Per2::Luc were synchronized with 1 μM dexamethasone (DEX) for 2 hours 
and then continuously treated with KK-S6 or vehicle (DMSO) throughout 
the circadian cycle. KK-S6 treatment caused an attenuation in the 
amplitude of reporter-induced luciferase oscillations in a dose-dependent 
manner but did not alter the period length over the range of concentrations 
tested (Fig. 12A and B). I further investigated whether oscillations in the 




explant slices derived from Per2 knock-in mice. Application of KK-S6 during 
the trough of the Per2::Luc oscillation significantly attenuated the amplitude 
of the oscillations. Following KK-S6 wash-out, the oscillations rebounded to 
their previous profiles (Fig. 12C). Statistical analysis revealed that the mean 
amplitude during KK-S6 treatment was significantly lower than that at pre- 
and post-treatment (wash-out), but the periodicity of the Per2::Luc 
oscillation was unaltered. These data indicate that repressive 
transcriptional activity of 2×RORE::Luc by KK-S6 may be due to a decrease 
in the amplitude of oscillations produced by the circadian clock.  
 
KK-S6 enhances the action of REV-ERBα  
 
I next assessed whether KK-S6 acted via REV-ERBα when full-length 
Rev-erbα was either over-expressed or endogenously depleted. KK-S6 
treatment slightly repressed RORE-mediated reporter activity, compared 
with the control treatment, and luciferase activity was further down-
regulated when Rev-erbα was over-expressed (Fig. 13A). KK-S6 
suppressed Bmal1::ELuc (emerald luciferase) activity in WT MEFs, but its 
repressive effect on RORE-mediated transcription was lost in MEFs derived 
from Rev-erbα knock-out mice (Fig. 13A). It thus appears that KK-S6 may 
act at the level of REV-ERBα. I next attempted to determine whether KK-S6 
could modulate mRNA expression levels in HepG2 cells of several genes 
that act downstream of REV-ERBα and contain the RORE cis-element in 




and Plasminogen activator inhibitor-1 (Pai-1) (Wang et al., 2006) promoters 
each have two putative ROREs, whereas that of Citrate synthase 
(Crumbley et al., 2012) has one. All three genes can be directly regulated 
by REV-ERBα (Harding et al., 1993). Treatment with KK-S6 repressed the 
transcription levels of these genes as strongly as heme, the endogenous 
ligand, and GSK4112, a REV-ERBα agonist (Fig. 13B). KK-S6 treatment 
produced as great a decrease in BMAL1 protein expression as treatment 
with heme, whereas lithium (LiCl) treatment increased the level of BMAL1 
(Fig. 13C). Lithium is an inhibitor of GSK3β that accelerates the rate of 
phosphorylation, leading to degradation of REV-ERBα protein (Yin et al., 
2006; Osland et al., 2011). Interestingly, KK-S6 treatment resulted in more 
significant decreases in levels of endogenous mRNA of genes acting 
downstream of REV-ERBα as well as in the level of BMAL1 than RORE-
mediated transcription activity. It appears that a post-translational 
modification process may be involved in, or may modify, the effect of KK-S6 
on molecular clock-related targets.  
 
KK-S6 is not directly interact with LBD of REV-ERBα 
 
I next performed the mammalian one-hybrid assay, to determine whether 
KK-S6 directly bound the LBD of REV-ERBα. As a control group upstream-
activation sequence (UAS)::Luc activity was reduced by Rev-erbα-LBD 
construct in a dose-dependent manner (Fig. 14A). GSK4112 (15 μM), which 




repressive activity, was used as a positive control. Although GSK4112 acted 
as expected, KK-S6 (10 μM) did not (Fig. 14B). It thus appears that KK-S6 
does not directly interact with the LBD of REV-ERBα to repress the activity 
of the 2×RORE::Luc reporter. So, further studies will be need to how KK-S6 























Figure 6. Validation of the 2×RORE::Luc reporter system. (A) A 
schematic representation of the 2×RORE::Luc reporter construct. It 
contains two copies of the RORα/REV-ERBα-response element (RORE; 
RORE1: AAGTAGGTTA; RORE2: AAGTAGGTCA) from the Bmal1 
promoter region (171 bp) that drive luciferase reporter expression. (B) 
Circadian oscillations in expression level of the 2×RORE::Luc reporter in 
fibroblast cells measured using a real-time bioluminescence monitoring 
system. (C) Transient expression of RORα (0, 12.5, 25, 50 and 100 ng) 
gradually induced reporter activity whereas expression of REV-ERBα (0, 
12.5, 25, 50 and 100 ng) gradually repressed reporter transcriptional 
activity in NIH3T3 cells. The two bottom panels show the combined effect of 
RORα and/or REV-ERBα. The increase in reporter activity produced by 
RORα (12.5 ng) was dose-dependently decreased by REV-ERBα (0, 12.5, 
25, 50 and 100 ng) (bottom left). The depression of reporter activity caused 
by REV-ERBα (100 ng) was dose-dependently reversed by the addition of 
RORα (0, 12.5, 25, 50 and 100 ng) (bottom right). Experiments were 

























Figure 7. Summary of chemical library screening by cell-based assay. 
(A) NIH3T3 cells were transiently transfected with the 2×RORE::Luc 
reporter before treatment with 1128 different drug-like compounds at a final 
concentration of 20 μM. Luciferase activity was calculated by comparing 
luminescence levels with a control DMSO-treated group and normalized on 
Renilla luciferase activity. Black: compounds with no significant effect; blue: 
compounds with ∆50% change; orange: compounds with ∆100% change; 
red: compounds with ∆200% change. Experiments were replicated three to 
six times. (B) Pie-chart summarizing the screening results: 260 compounds 
repressed reporter activity whereas 33 compounds induced activity. The 
remainder (830 compounds) had no effect on reporter activity. Fold change 
cut-off is with reference to the control (set at 1.0). White: no change; gray: 
damaged; blue: activity induced; orange: activity repressed. Experiments 



























Figure 8. Structure and activity of the KK-S family of compounds. (A) 
Classification of the compounds 293 producing primary hits in the screen 
into 14 groups (A to N) based on their structural similarities (White: 
repressor; black: inducer). (B) Basic structural scaffold of 68 chemical 
compounds in the KK-S family. Selected ten compounds among the KK-S 
family shared a common moiety but varied with respect to the residues at R. 
(C) NIH3T3 cells expressing 2×RORE::Luc were treated with 10 μM of 68 
compounds from the KK-S family. Of these, ten compounds (open bars) 
were sorted by structural analogies which displayed their repressive effect 
on 2×RORE::Luc reporter activity. *p < 0.05, **p < 0.01 compared to vehicle 


































Figure 9. Dose-response curves showing the effect on activity of the 
2×RORE::Luc reporter of ten compounds from the KK-S subfamily. 
Dose-response curves showing the effect of ten compounds selected from 
the KK-S subfamily on RORE-mediated transcription. Luciferase activity in 
NIH3T3 cells harboring the 2×RORE::Luc reporter was monitored in the 
presence of various concentrations of compound (7 points of 3-fold dilution 
series in DMSO). The grey dot represents cells damaged by a high 
concentration of compound. Experiments were replicated six to nine times 



























Figure 10. ROREs are essential for oscillations in reporter activity of 
the circadian nuclear receptors RORα and REV-ERBα. (A) Schematic 
diagrams of mutated RORE reporter constructs. Wild-type RORE contains 
two copies of the cis-element (RORE1 and RORE2). GG was mutated to 
CA in RORE1 and/or RORE2 to produce mRORE1, mRORE2 and 
mRORE1/2 reporters. (B) NIH3T3 cells were transfected with a luciferase 
reporter containing wild-type RORE, mRORE1, mRORE2 or mRORE1/2. 
Mutations at one or both sites completely abolished the suppression of 
luciferase reporter by RORα and REV-ERBα. Experiments were replicated 
six times. Data shown are the means ± SEM. (C) Comparison of 
bioluminescence profiles after dexamethasone treatment of cells stably 
transformed with luciferase reporters containing mutated ROREs. Two 
hours after dexamethasone (1 μM) treatment, reporter activity of each cell 
was recorded using a real-time luminescence monitoring system. The 
presence of mutated ROREs (mRORE1, mRORE2, and mRORE1/2) totally 





















Figure 11. Use of a mutated 2×RORE::Luc reporter system to validate 
the specific affinity of KK-S6 for RORE reporter activity. (A) Cells 
expressing wild-type RORE (2×RORE::Luc) or mutated RORE (RORE1/2) 
were cultured on 24-well plates for 24 hours and then treated with vehicle 
(0.05% DMSO) or one of the ten selected compounds at 5 μM 
concentration. **p < 0.01 compared to vehicle DMSO-treated group, ††p < 
0.01 vs wild type with the same treatment. Data shown are means ± SEM 
(n = 6-9). (B) Chemical structure of KK-S6. (C) The effect of KK-S6 on 
activity of the 2×RORE::Luc reporter is sequence-specific. KK-S6 
repressed the activity of the wild-type 2×RORE::Luc reporter but this effect 
was lost in the presence of a single mutated RORE (mRORE1 and 
mRORE2) or if both ROREs were mutated (mRORE1/2). *p < 0.05 
compared to vehicle DMSO-treated group. Data shown are means ± SEM 


























Figure 12. KK-S6 affects the amplitude but not the period length of 
circadian oscillations in cells and of Per2::Luc activity in the SCN ex 
vivo. (A) NIH3T3 cells stably harboring the 2×RORE::Luc reporter were 
synchronized with 1 μM dexamethasone (DEX) for 2 hours and then treated 
with vehicle (0.05% DMSO) or KK-S6 (1.25, 2.5 and 5 μM). The level of 
bioluminescence emitted in the presence of luciferin substrate was 
monitored every 2 minutes for 72 hours with a real-time luminescence 
monitoring system. (B) Stable NIH3T3 cells harboring luciferase driven by 
the mouse Per2 promoter (Per2::Luc) were synchronized with 1 μM 
dexamethasone (DEX) for 2 hours and then treated with vehicle (0.05% 
DMSO) or KK-S6 (1.25, 2.5 and 5 μM). Bioluminescence levels were 
monitored, as previously described. (C) The effect of KK-S6 on luciferase 
activity in SCN explants from Per2::Luc knock-in mice. An SCN-explant 
slice (300 μM) was pre-incubated in culture medium containing D-luciferin 
(0.3 mM) and KK-S6 (5 μM) was added to the recording medium during the 
trough after the third expression peak. Bioluminescence was continuously 
measured using a real-time bioluminescence monitoring system. The right-
hand panels show the reductions in amplitude but not in period length 

















Figure 13. KK-S6 action is dependent on REV-ERBα. (A) NIH3T3 cells 
were transfected with 2×RORE::Luc and/or Rev-erbα and treated with 
vehicle (0.05% DMSO) or KK-S6 (10 μM). KK-S6 significantly repressed 
luciferase reporter activity in cells expressing Rev-erbα. Luciferase activity 
was normalized to Renilla luciferase activity. **p < 0.01 compared to vehicle 
DMSO-treated group. Experiments were replicated six times and data 
shown are means ± SEM. (B) Wild-type or Rev-erbα knock-out MEFs were 
obtained from crosses between Bmal1::ELuc/Rev-erbα+/- and Rev-erbα+/- 
mice and treated with KK-S6 (5 μM) for 24 hours. The extent of repression 
was calculated by dividing luciferase activity in the KK-S6-treated group by 
that in the control, DMSO-treated group. The effect of KK-S6 on RORE-
mediated transcription was significantly attenuated in Rev-erbα knock-out 
MEFs, as determined by luminescence levels produced by activity of the 
Bmal1::ELuc reporter. **p < 0.01 compared to vehicle DMSO-treated group. 
Experiments were replicated three times and data shown are the means ± 
SEM. (C) mRNA expression of genes acting downstream of REV-ERBα is 
altered by KK-S6. HepG2 cells were treated with vehicle (0.05% DMSO) or 
KK-S6 (5 μM) for 24 hours. Cells were harvested and levels of Bmal1, Pai-1, 
and citrate synthase mRNA were analyzed using real-time PCR. Each 
value was normalized against the level of expression of TATA-binding 
protein (Tbp). **p < 0.01 compared to vehicle DMSO-treated group. Heme 
(30 μM) and GSK4112 (15 μM) were used as positive controls. Experiments 
were replicated four to nine times and data shown are the means ± SEM. 












deprivation, NIH3T3 cells were treated with vehicle (0.05% DMSO) or heme 
(30 μM), lithium (10 mM), KK-S6 (5 μM) for 24 hours. BMAL1 protein levels 
were determined using western blot analysis with anti-BMAL1 antibody and 
quantitated by densitometry. Relative BMAL1 protein levels (A.U) were 
measured twice. Data shown are means ± SEM. *p < 0.05 compared to 





































Figure 14. Effect of KK-S6 on the ligand-binding domain (LBD) of REV-
ERBα in a mammalian one-hybrid assay. (A) NIH3T3 cells were 
transiently co-transfected with UAS::Luc reporter and Rev-erbα LBD 
constructs (50, 100, and 200 ng). Reporter activity was suppressed by the 
addition of LBD of REV-ERBα in a dose-dependent manner. Luciferase 
activity was normalized on that of the control group. Experiments were 
replicated three times and data shown are means ± SEM. (B) NIH3T3 cells 
were co-transfected with UAS::Luc reporter and Rev-erbα LBD constructs 
(50 ng) and then treated with GSK4112 (15 μM) or KK-S6 (10 μM). 
Experiments were replicated six times and data shown are means ± SEM. 



























Figure 15. Hypothesized mechanisms of action of KK-S6.  
KK-S6 binds to the REV-ERBα protein except its ligand-binding domain 
(LBD) and stimulates the repressive activity of REV-ERBα through specific 
cis-element RORE, thereby leads to reduced Bmal1 action. However, 






























Recent studies show that REV-ERBα plays an important role in the 
regulation of circadian rhythms as well as in many other functions, including 
metabolic and energy homeostasis, inflammation, neural pathways and 
behavior (Everett et al., 2014). I used cell-based screening with a RORE-
driven luciferase reporter to identify a novel modulator of REV-ERBα, KK-
S6. This is a small, synthetic molecule, the chemical structure of which is 
distinct from several previously reported synthetic REV-ERBs agonists 
(Grant et al., 2010; Solt et al., 2012). KK-S6 repressed RORE-mediated 
transcriptional activity but not activity of a mutated RORE reporter. 
Moreover, although KK-S6 negatively regulated levels of Bmal1 mRNA and 
protein, it did not affect transcriptional activity of Bmal1 in MEFs derived 
from Rev-erbα knock-out mice. This compound significantly altered the 
amplitude of circadian oscillations of RORE and/or Per2 dose-dependently 
in vitro and ex vivo, but did not affect the period length of these rhythms. 
Further experimental evidence indicated KK-S6 acted via REV-ERBα: 
firstly, when REV-ERBα was over-expressed, KK-S6 enhanced repression 
of RORE-mediated reporter activity in wild-type MEFs, but this effect 
disappeared in MEFs derived from Rev-erbα knock-out mice. Secondly, 
KK-S6, like heme (the endogenous ligand for REV-ERBα), repressed 
Bmal1 expression at the transcriptional and protein levels. However, a 




ERBα was a molecular target of KK-S6.  
As described above, GSK4112 was identified by FRET analysis using the 
LBD of REV-ERBα and the interacting domain of NCOR1 (Grant et al., 
2010). However, KK-S6 did not directly interact with the LBD of REV-ERBα 
in a mammalian one-hybrid assay. According to a previous report (Negoro 
et al., 2013), the A/B region of REV-ERBα competes with its LBD and 
functions as an activation domain. We cannot, therefore, rule out the 
possibility that KK-S6 acts by interrupting the REV-ERBα A/B region and 
thus indirectly affecting its repressive activity. Further studies are needed to 
examine this point.  
Another possibility is that KK-S6 affects the process of post-translational 
modification of REV-ERBα, and thus modulates its activity through protein 
stability. REV-ERBα promotes ubiquitin-dependent proteosomal 
degradation by E3 ligases, such as ARF-BP1 and PAM (Yin et al., 2010). 
Moreover, glycogen synthase kinase 3β (GSK3β) stabilizes REV-ERBα by 
phosphorylation and thereby can accelerate degradation of the protein. 
Lithium is a competitive inhibitor of GSK3β, and inhibits GSK3β-mediated 
phosphorylation and regulates stability of REV-ERBα (Yin et al., 2010). 
Interestingly, lithium treatment does not alter the amplitude of Bmal1::Luc 
rhythms in reporter cells containing RORE elements from the Bmal1 
promoter but it does increase period length (Li et al., 2012). It appears that 
GSK3β may not be the crucial factor for amplitude modulation. I tested the 
effect of KK-S6 on the amplitude of RORE reporter rhythms and the results 




REV-ERBα forms a complex with the co-repressors NCOR and HDAC3, 
which suppresses the transcription of target genes upon activation by its 
ligand (Liu et al., 2007). Several pharmacological approaches to defining 
the biological role of REV-ERBα have used the synthetic compound 
GSK4112 and its analogs SR9009 and SR9011. All three compounds share 
a common tertiary amine core which induces the recruitment of an NCOR 
fragment to REV-ERBα, enabling activation (Trump et al., 2013). When 
GSK4112 was tested in a REV-ERBα/NCOR FRET analysis it caused a 
similar increase in the FRET signal to the endogenous porphyrin ligand, 
heme (Grant et al., 2010). By contrast, hemin, the Fe (III) form of heme, 
decreased NCOR binding to REV-ERBα, because the conformation of the 
receptor was sensitive to the oxidation state of the metal in the porphyrin 
ligand. This suggests that their binding as ligands to REV-ERBα is mutually 
exclusive. Although KK-S6 does not have a metal-incorporated chain in its 
structure, it has an alkyl group that potentially generates free radicals and 
so may affect the radical state and protein folding of REV-ERBα. However, 
it is unclear whether KK-S6 represses the RORE transcriptional activity 
through a similar mechanism, and further studies are needed to identify the 
precise molecular mechanism of its action. 
REV-ERBα and REV-ERBβ are functionally redundant for the generation 
of rhythms in Bmal1 expression and depletion of either is not sufficient to 
disrupt Bmal1 rhythmicity (Liu et al., 2008). Cells from which Rev-erbα has 
been knocked-out show partially disrupted rhythmicity that may result from 




expressed in cells lacking Rev-erbα. As KK-S6 action was lost in cells 
specifically depleted of REV-ERBα (Fig. 13A), other RORE-responsive 
clock genes could not be the target proteins of this synthetic molecule. 
Several genes acting downstream of REV-ERBα, including Bmal1, Pai-1 
and Citrate synthase, were significantly decreased by KK-S6 at the 
transcriptional level. Pai-1 plays a critical role in inflammation and the 
fibrinolytic system whereas Citrate synthase, a citrate producer, is heavily 
involved in lipogenesis and cholesterologenesis (Wang et al., 2006; 
Crumbley et al., 2012). It is thus worth noting that KK-S6 could control 
metabolic homeostasis, as REV-ERBα is a link between the circadian 
timing system and metabolism. 
In summary, I identified a novel modulator of the mammalian clock that 
acts through a RORE-mediated mechanism by cell-based screening 
method. Further investigations are needed whether KK-S6 might work via 


















A circadian action of Rev-erbα on compulsive  













Hedonic overconsumption of sucrose may cause a physiological 
imbalance in energy metabolism, which is reinforced by the dopamine 
(DA)-associated reward pathway in the midbrain. The circadian nuclear 
receptor, Rev-erbα contributes to transcriptional control of tyrosine 
hydroxylase (TH) production via competition with nuclear receptor 1-related 
protein (Nurr1) which is a transcriptional activator of DA biosynthesis in the 
ventral tegmental area (VTA). Here, I examine the hypothesis of whether 
Rev-erbα may be involved in regulation of the midbrain dopamine-reward 
system in compulsive sucrose-seeking mice model. Mood-related 
behavioral tests revealed that sucrose-bingeing mice exhibit more anxiety-
like behavior at dusk and depressive-like behavior at dawn compared with 
control mice, respectively. Interestingly, the mRNA expression of ∆Fos B, a 
molecular marker of addiction, was upregulated in the nucleus accumbens 
(NAc) of sucrose-bingeing mice, as was Nurr1 mRNA expression. However, 
the latter returned to normal levels after 10 days sucrose withdrawal, 
accompanied by an increase in Rev-erbα mRNA expression. Taken 
together, Rev-erbα may act as a “buffer” to maintain normal DA tone and 
homeostasis in response to alteration of DA transmission after compulsive 
sucrose consumption. 
 






Nutrients, fats, and sugars cause a variety of changes in brain 
metabolism, emotional behavior, and overall physiology via specific action 
mechanisms (Avena et al., 2009). However, repetitive, long-term, 
compulsive overconsumption of food leads to social problems and obesity-
related physical disabilities (Tanofsky-Kraff et al., 2006), and was 
characterized as an official eating disorder (binge-eating disorder, or BED) 
in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition 
(DSM-5) in 2013. Individuals with BED struggle more frequently with stress, 
unstable emotions, and lack of impulse control than those without an eating 
disorder (Hu and Malik, 2010). Depression, anxiety, and substance abuse 
can also accompany BED (Davis and Claridge, 1998). Given the severe 
symptoms of BED, researchers and clinicians recognize the importance of 
new interventions for its successful management. 
Sucrose (table sugar) is a disaccharide carbohydrate that is a useful 
energy source for the body. Nevertheless, sucrose-containing foods are 
commonly abused by patients with BED. A sucrose binge is triggered by 
aberrant neural activity within the reward circuit of the mesolimbic 
dopamine (DA) system (termed the reward pathway), which begins in the 
ventral tegmental area and connects to the nucleus accumbens (NAc) 
(Rada et al., 2005). Hence, many researchers have attempted to elucidate 




underpinnings of bingeing using sucrose-bingeing rodent models (Avena et 
al., 2008; Yasoshima and Shimura, 2015). Nevertheless, few rodent models 
for binge-like sucrose overconsumption are currently well established. 
During the reward process, the mesolimbic dopaminergic (DAergic) 
system fosters motivational or “wanting” behavior. Binge episodes increase 
extracellular DA levels by blocking DA reuptake in the NAc, followed by 
downregulation of acetylcholine in the same brain region. In this way, the 
actions of bingeing are comparable to the effects of drug abuse (Trinko et 
al., 2007; Giros et al., 1996). Accordingly, irregular DAergic functioning is a 
key focus of BED research (Davis et al., 2009). On the other hand, the 
endogenous mu-opioid system, particularly within the ventral striatum and 
the amygdala, regulates the positive hedonic response to sweeteners, 
which is termed “liking”. Repeated sucrose consumption stimulates the 
release of opioids (e.g., enkephalin, β-endorphin), triggering a 
compensatory mechanism such that opioid peptides are downregulated 
due to transcriptional control of gene expression (Davis et al., 2009). 
Meanwhile, ∆FosB, a sustained molecular switch for addiction responses, 
rapidly accumulates within the NAc after repeated administration of drugs 
of abuse (Nestler et al., 2001). Such neurochemical alterations are 
correlated with variations in gene expression to maintain their homeostasis. 
Therefore, gene therapy approaches are one focus of BED research. 
Several studies suggest that crosstalk between DAergic signaling and 
the circadian clock system is essential for DA homeostasis during various 




turnover (Chung et al., 2014; Hampp et al., 2008). Defective circadian clock 
genes result in midbrain DAergic system dysfunction, thereby contributing 
to severe mood disorders (Falcon et al., 2013; Spencer et al., 2013; Bundel 
et al., 2013; McClung et al., 2005). Recently, the circadian nuclear receptor, 
Rev-erbα was proposed as a novel regulator of cyclic DA synthesis through 
suppression of tyrosine hydroxylase (TH), a rate-limiting enzyme for DA 
biosynthesis. Rev-erbα competes with Nurr1, a transcriptional activator of 
DA biosynthesis, to affect DA transcription (Chung et al., 2014). Local 
inhibition or genetic depletion of Rev-erbα, especially in the ventral 
midbrain, engenders a mania-like phenotype with a circadian nature 
(Chung et al., 2014), whereas Rev-erb agonism overturns the reward 
behavior associated with wheel running and drug preference (Banerjee et 
al., 2014). However, it is still unclear whether Rev-erbα directly interferes 
with the reward system in the DA circuit at the transcriptional level. 
Impairment of liver metabolism is probably the most significant health 
consequence of bingeing. Binge consumption of sucrose contributes to the 
development of fatty liver and metabolic imbalances (Bray et al., 2004). 
Furthermore, enhanced sugar signaling induced by a high-sucrose diet 
accelerates the mRNA levels of genes associated with fat biosynthesis (e.g., 
acetyl CoA transferase (ACC) and fatty acid synthase, leading to 
intracellular triglyceride accumulation in the liver (Janevski et al., 2012). 
Gene expression levels of intestinal sweet taste receptors and sugar 
transporters are also affected (Wideman et al., 2005). Although compulsive 




recover from the binge through homeostatic mechanisms 
(synthesis/oxidation of fat) after sucrose withdrawal is still unknown.  
The mechanisms underlying gene expression variations that occur 
during sucrose consumption or sucrose withdrawal are poorly understood 
with reference to Rev-erbα and other clock genes. Here, I present a novel 
circadian role for Rev-erbα as a buffer in the reward system. I show that 
Rev-erbα upregulation in sucrose-seeking mice with sucrose withdrawal 
downregulates abnormally high expression of Nurr1 in the NAc provoked by 
a diet containing sucrose. This result implies that Rev-erbα acts as a buffer 
during the withdrawal period, but not during the binge stage. Further, it is 
suggested that Rev-erbα maintains reward activity homeostasis in 
response to sucrose-induced DA alterations, and thus may serve as a 












MATERIALS AND METHODS 
 
Animals and sampling. Adult male C57/B6 strain mice (Mus musculus; 8–
10 weeks of age, weighing 25–30 g) were used in this study. Mice were 
kept in a temperature-controlled room at 22 ± 2°C and 50–60% relative 
humidity under a 12 h light/12 h dark (LD) cycle (lights on/off at 5:00 
pm/5:00 am). The animals had ad libitum access to food and water, except 
for during the test period. After entrainment for > 10 days under LD 
conditions, mice were subjected to scheduled behavioral tests (see below) 
performed at circadian time (CT) 0 and CT 12. Individual mice were also 
touched, lifted, or held for 7 days (10 min per day) before each behavioral 
test to habituate them to handling. After testing, mice were sacrificed at CT 
0 and CT 12 by cervical dislocation, and brains were dissected with 
reference to a brain matrix using a microknife. All procedures were 
approved by the Institutional Animal Care and Use Committee of Seoul 
National University. 
 
Sucrose preference test. Mice were assessed for sucrose preference in a 
sucrose versus water two-bottle choice test. Once habituated to the 
experimental cage used for behavioral testing, each mouse was presented 
with two bottles, one containing water and the other containing a sucrose 
solution (2%, 10%, or 50% in water). After water deprivation for 3 h (from 




for 24 h. To prevent possible effects of side preference, the positions of the 
bottles were reversed halfway through the test. Water and sucrose 
consumption levels were measured by weighing the bottles pre- and post-
testing. Sucrose preference was calculated as a percentage of consumed 
sucrose solution relative to total liquid intake, with a 50% preference 
indicating that the animal drank equally from both bottles.  
 
Elevated plus maze (EPM) test. The EPM consists of two open arms (5 × 
30 cm) and two enclosed arms (5 × 30 cm) with 20 cm-high opaque walls. 
The EPM apparatus was elevated to a height of 50 cm above the ground. 
At the beginning of each trial, mice were individually placed in the center of 
the maze facing an open arm. Animals were allowed to freely explore for 10 
min, with their activity recorded by videotaping. Frequency and duration of 
arm entries were counted separately. An entry was defined as the 
movement of all four paws into an arm. All trials were conducted at dawn 
(CT 22–01) and dusk (CT 10–13). The maze was cleansed with 70% 
ethanol after each trial.  
 
Forced-swim test (FST). The despair-based FST was performed as 
previously described (Chung S et al., 2014). To quantify depression-related 
despair behavior, mice were placed into a glass cylinder (height = 30 cm, 
diameter = 15 cm) filled with water (21–25°C) to a depth of 15 cm. Within 
the testing period of 6 min, the activity of each mouse was recorded from 




the absence of limb movement in water, and was scored as the percentage 
of the time spent immobile during the last 4 min of the test. 
 
Aggression test. Mice were individually isolated for > 1 week before 
testing. A male BALB/c mouse (9–10 weeks of age) was used as an 
intruder, and had a similar body weight to the test mice. For aggression 
tests, the resident mice were allowed to interact with the intruder for 5 min. 
A new intruder mouse was used in each test. The data points were 
recorded in terms of attack duration, frequency, and latency. Aggressive 
behaviors were defined as tail rattling, biting, chasing, and cornering. 
 
Wheel running. The mice were caged in wheel running assembly at 9-10 
weeks of age for wheel running activity experiments. After 2 week of 
entraining period, the wheel running activity was recorded at 6 min intervals 
and the raw data files were analyzed as described previously (Park et al., 
2012). Mice were kept under a standardized light condition, 12 h light/12 h 
dark (LD) cycle, during 40 days of test period and they enter the 12 h dark/ 
12 h dark (DD) cycle for 20 days with diet containing sucrose.   
 
RNA isolation and real-time polymerase chain reaction (PCR). To 
quantify mRNA expression of genes of interest, mice were sacrificed, and 
tissues (NAc and liver) were rapidly removed, frozen in liquid nitrogen, and 
stored at −70°C before use. Total RNA was isolated using the single-step 




The RNA (3 μg) was reverse-transcribed with Moloney murine leukemia 
virus (M-MLV) reverse transcriptase (Promega). Real-time PCR was 
performed in the presence of SYBR Green I (Sigma). Gene expression 
levels were normalized against those of the glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) transcript. Primer sequences used in real-time 
PCR were as follows: Bmal1 upstream (up): 5’-TTA AGA GGT GCC ACC 
AAT CC-3’; Bmal1 downstream (dn): 5’-TTC CCT CGG TCA CAT CCT AC-
3’; Clock up: 5’-TTG CTC CAC GGG AAT CCT T-3’; Clock dn: 5’-GGA GGG 
AAA GTG CTC TGT TGT AG-3’; Cry1 up: 5’-CTG GCG TGG AAG TCA 
TCG T-3’; Cry1 dn: 5’-CTG TCC GCC ATT GAG TTC TAT G -3’; Per2 up: 
5’-ATG CTC GCC ATC CAC AAG A-3’; Per2 dn: 5’-GCG GAA TCG AAT 
GGG AGA AT-3’; Rev-erbα up: 5’-AAG ACA TGA CGA CCC TGG AC-3’; 
Rev-erbα dn: 5’-GAG TCA GGG ACT GGA AGC TG-3’; RORα up: 5’- TCG 
CAG CGA TGA AAG CTC AA -3’; RORα dn: 5’- GAT GTT GTA GGT GGG 
CGT CA -3’; D1R up: 5’-GAA CCC AGA AGA CAG GTG GA -3’; D1R dn: 5’- 
GCT TAG CCC TCA CGT TCT TG -3’; D2R up: 5’-AAA CTC GTT GAG 
GCT AGG GC -3’; D2R dn: 5’- TGC GGG TTC TCT TCA AAC CA-3’; DAT 
up: 5’-CCT GGT TCT ACG GTG TCC AG-3’; DAT dn: 5’-GCT GAC CAC 
GAC CAC ATA CA-3’; TH up: 5’-AGT TCT CCC AGG ACA TTG GAC TT-3’; 
TH dn: 5’-ACA CAG CCC AAA CTC CAC AGT-3’; Nurr1 up: 5’-TGA AGA 
GAG CGG ACA AGG AGA TC-3’; Nurr1 dn: 5’-TCT GGA GTT AAG AAA 
TCG GAG CTG-3’; CPT1α up: 5’-ACA GTG GGA CAT TCC AGG AG-3’; 
CPT1α dn: 5’-GAA CTT GCC CAT GTC CTT GT-3’; PPARα up: 5’-AGG 




GCA TT -3’; ACC up: 5’-ACT GAT CGC AGA GAA AGT GCA-3’; ACC dn: 
5’-CTC CCA ACA TGG TGT CAG GTC-3’; ∆Fos B up: 5’-AAA ACA AAC 
AAA CCC GCA AG-3’; ∆Fos B dn: 5’-CAG AGA CGG AGC ACA AAA CA-3’; 
GAPDH up: 5’-CAT GGC CTT CCG TGT TCC TA-3’; GAPDH dn: 5’-CCT 
GCT TCA CCA CCT TCT TGA-3’. PCR reaction mixtures were first 
incubated at 94°C for 10 min, followed by 50 cycles of 95°C for 15 sec, 
62°C for 30 sec, and 72°C for 30 sec. 
 
Statistical analysis. All quantifiable data were homogeneously distributed, 
and are given as the means ± the standard error of the mean (SEM). Group 
differences were evaluated using the Student’s t test or one-way analysis of 
variance and GraphPad Prism software (GraphPad Software, Inc.). P-

















C57/B6 mice prefer sucrose to water 
 
I first confirmed that C57/B6 mice have a strong preference for sucrose 
over water using the sucrose preference test. In brief-access tests, water-
deprived mice were presented with water and 2% sucrose for 24 h, and 
sucrose preference was defined as the percentage of consumed sucrose 
relative to the total amount of liquid intake. Mice displayed an attraction to 
sucrose that was nearly three times that of water (sucrose preference = 
71.7% ± 6.16) (Fig. 16A). Generally, mice consume more sucrose at a 
concentration of 10% compared with other sucrose concentrations (Lewis 
et al., 2005). Therefore, we assessed whether our C57/B6 mice also 
preferred 10% sucrose relative to 2% or 50% sucrose. In agreement with 
the previous work, the mice consumed the most sucrose at a concentration 
of 10% (Fig. 16B). 
 
Validation of the sucrose-bingeing mouse model 
 
To investigate the role of the Rev-erbα gene in reward behavior, I 
established an animal model exhibiting abnormal feeding behavior 
associated with sucrose. This animal model was based on the work of 




food for 12 h, followed by access to 10% sucrose and food for 12 h. Such a 
deprivation condition is often used to maximize the reward effect. The 
testing period lasted for 40 days (Group C; Fig. 17). This study also 
employed two negative control groups. The first group (Group A) 
experienced no deprivation, with free access to water and food at all times, 
and the second group (Group B) experienced food deprivation for 12 h 
during the day, followed by access to water, not sucrose, and food for 12 h 
at night. 
Significant differences in food and liquid intake were observed across 
the three groups. Providing water after 12 h food deprivation (Group B) 
resulted in increased food, but not liquid, intake relative to the other two 
groups, whereas providing 10% sucrose after 12 h food deprivation (Group 
C) led to a gradually increased intake of 10% sucrose, but not food (Fig. 
18A). Nevertheless, total energy intake from food and liquid was not 
significantly different between Groups B and C (Fig. 18B). Group B 
consumed more food to satisfy hunger, while Group C consumed more 10% sucrose 
rather than food. Although total energy intake was similar between Groups 
B and C, only Group C exhibited body weight gain during the testing period 
(Fig. 18C), indicating that sucrose consumption leads to increased body 
mass. 
 






To determine whether sucrose-seeking behavior leads to circadian 
cycle-associated emotional and genetic alterations, I tested the three 
groups of mice at subjective dawn (CT 22–01) and subjective dusk (CT10–
13). Sucrose-bingeing mice generally display high levels of anxiety, low 
risk-taking behavior, and low impulsivity (Avena et al., 2008). In the EPM 
test, Group C entered the open arm of the maze less frequently and spent 
less time in the open arms compared with Group A and B; these daily 
behavioral variations (indicative of increased anxiety) were observed at 
dusk, but not at dawn (Fig. 19A). I further evaluated depression-like 
behavior in the FST. Here, Group C showed greater periods of immobility 
than control mice at dawn, but not at dusk, whereas Group B exhibited 
manic-like behavior, rather than depressive behavior, at dawn (Fig. 19B). 
Possibly, the sucrose reward satisfied the hunger of Group C, thereby 
reversing the hyperactivity caused by food deprivation. Lastly, all mice 
exhibited daily variation in the aggression test, but no significant differences 
were found among the groups (Fig. 19C). These results demonstrate that 
mice in Group C had high levels of anxiety and depressive behavior, similar 
to the other reports of sucrose-bingeing mice (Avena et al., 2008). 
To explore changes in genes associated with addiction, I measured 
∆FosB mRNA expression in the NAc (Fig. 19D) of mice from all three 
groups. ∆FosB transcripts are selectively induced within the NAc in 
association with addiction behavior, representing a change in brain 
chemistry that contributes to the addiction phenotype (Nestler et al., 2001). 




by ~50% in the NAc of Group C versus Group A at dusk (Fig. 19E). 
Furthermore, the peak of increased ∆FosB expression was coincided 
temporally with the sucrose reward. 
 
Nurr1 mRNA expression is significantly increased in the NAc of 
sucrose-bingeing mice 
 
Sucrose-bingeing mice display neurochemical signs of DA 
hypersensitivity, and release more DA in response to sucrose intake than 
normal (Avena et al., 2006). A recent attempt to identify a novel role of the 
circadian nuclear receptor, Rev-erbα, in DA biosynthesis showed that Rev-
erbα can influence reward activity in the mesolimbic DA system (Chung et 
al., 2014). I hypothesized that Group C mice would overexpress Nurr1 in 
the NAc in response to sucrose bingeing. Intriguingly, Nurr1 mRNA 
expression levels were significantly upregulated in Group C versus Group A 
at dusk, but Rev-erbα, TH, and RORα remained unaltered at that time (Fig. 
20). I speculate that compulsive sucrose consumption during the testing 
period resulted in increased biosynthesis and release of DA in the NAc via 
Nurr1 induction. 
I assessed mRNA expression levels of additional DAergic/clock-related 
genes in the NAc (Bmal1, Clock, Cry1, Per2, DR1, DR2, and DAT). 
However, no significant differences were observed compared with control 
Group A, except for Bmal1 expression in Group B (Fig. 21). Although Bmal1 




impact the overall transcription of clock-related genes.  
 
Rev-erbα acts as a buffer to control Nurr1 expression in the NAc in 
response to sucrose bingeing 
 
To test whether the absence of sucrose can reverse abnormal Nurr1 
expression, I subjected sucrose-bingeing mice to a sucrose withdrawal 
period of 10 days and named Group C’. Group C no longer overconsumed 
10% sucrose after the withdrawal period when we provided Group C’ with 
10% sucrose again, and ∆FosB mRNA expression also returned to normal 
levels (Fig. 22A). Surprisingly, overexpression of Nurr1 mRNA returned to 
baseline levels after 10 days of sucrose withdrawal. Rev-erbα expression 
increased by nearly 3-fold in the NAc at dusk (Fig. 22B). Sucrose 
withdrawal also led to a reduction in expression of RORα, whose protein 
product is a competitive inhibitor of Rev-erbα in the molecular clock 
machinery, but not in the expression of other clock-related genes (Fig. 22B 
and 23). These findings suggest that Rev-erbα plays a critical role in 
maintaining DA homeostasis. 
 
Liver fat metabolism is altered in sucrose-bingeing mice and can 
be reversed by sucrose withdrawal 
 
I next assessed whether sucrose bingeing causes changes in liver fat 




fat storage/oxidation, such as ACC, a key substrate for fatty acid synthesis. 
ACC mRNA was expressed at similar levels in control mice (Groups A and 
B), but sucrose-bingeing mice (Group C) exhibited increase expression of 
this gene. Interestingly, ACC mRNA expression was reduced after sucrose 
withdrawal (Fig. 22C). In contrast, mRNA levels of the lipid oxidative 
enzyme, carnitine palmitoyltransferase 1α (CPT1α), and its transcription 
factor, peroxisome proliferator-activated receptor α (PPARα), were 
increased upon sucrose withdrawal (Fig. 22C). From these data, I 
hypothesize that compulsive sucrose consumption induces fat synthesis, 
whereas sucrose withdrawal reverses abnormal fat accumulation by 
accelerating fat oxidation to maintain lipid homeostasis. 
 
Impaired wheel running behavioral rhythm in sucrose-bingeing 
mice subjected to a dark/dark (DD) cycle 
 
Finally, I evaluated the effect of a sucrose reward on pleasurable wheel 
running activity. No behavioral differences were observed among the three 
groups during the experimental period of 40 days under the normal 12 h/12 
h LD cycle. From these data, I speculate that the light cue may have 
masked the impact of the sucrose cue on regular activity rhythm. Therefore, 
I subjected mice to a DD cycle for 20 days. Because diurnal species like 
mice exhibit an endogenous circadian period of <24 h, their circadian 
activity rhythms shifted toward a shorter endogenous period in the absence 




C) showed unique patterns of activity rhythm relative to both Group A and B 
under DD conditions. In DD conditions, the initiation of wheel running in 
Group C correlated with the timing of the sucrose reward (Fig. 24A). 
Moreover, Group C consumed more food and 10% sucrose during the 
wheel running period under LD conditions (Fig. 24B) than detected 































Figure 16. Sucrose preference test in C57/B6 mice. (A) C57/B6 mice 
were given a choice between water or 2% sucrose after water deprivation 
for 3 h. Mice preferred the sucrose solution over water (sucrose preference 
= 71.7% ± 12.3%). Data are given as the means ± the SEM (n = 4). (B) 
Alterations of water, sucrose (2%, 10%, and 50%), and chow intake at 
baseline in C57/B6 mice. Mice consumed significantly more sucrose at a 
concentration of 10% relative to the other concentrations. Data are given as 







































Figure 17. Sucrose-bingeing mouse model. C57/B6 mice (Groups A, B, 
and C) were maintained on a 12 h/12 h LD cycle. Group A mice were 
allowed free access to water and rodent chow. Group B mice were allowed 
free access to water, plus chow starting 4 h into the dark phase after 12 h 
food deprivation. Group C mice were allowed access to 10% sucrose (in 
place of water) plus chow after 12 h food deprivation. The experiment was 
conducted for a total period of 40 days. This food deprivation scheme 



























Figure 18. Total caloric intake and body mass changes during the test 
period. (A) The weight of consumed food and fluid was determined daily in 
each group of mice for a total period of 40 days. Food-deprived (Groups B 
and C) or non-deprived (Group A) mice were presented with food and fluid 
(water for Groups A and B; 10% sucrose for Group C) at night, and total 
intake was calculated after 12 h. Group A and C mice showed similar food 
consumption, whereas Group B mice consumed more food during the test 
period than the other two groups. Group C mice consumed far more fluid 
than the other two groups. Data are given as the means ± the SEM (n = 6–
7 per group). (B) Total energy intake from food and fluid consumption. 
Although energy intake from food (3.97 kcal/g) in Group C was less than 
that in Group B, Group C mice also acquired calories from 10% sucrose 
(0.4 kcal/g). Therefore, the total caloric intake of Group B and C mice was 
similar. Groups B and C mice both consumed more calories than Group A 
mice. Data are given as the means ± the SEM (n = 6–7 per group). (C) 
Body mass was measured twice every week. Group C mice showed no 
significant change in body mass, whereas Group B mice showed marked 
weight loss during the last week of the test period. Data are given as the 






















Figure 19. Behavioral and gene expression alterations in sucrose-
bingeing mice. (A) Anxiety behavior in the EPM test. Group C mice spent 
significantly less time in the open arms, and showed a reduced total 
number of entries into the open arms at dusk (CT 10–13). No significant 
differences were observed among the three groups at dawn (CT 22–01). 
Data are given as the means ± the SEM (n = 6–7 per group; **P < 0.01, *P 
< 0.05 versus Group A). (B) Depressive-like behavior in the FST. Each 
group of mice was subjected to the test for 6 min. Group C mice showed 
more immobility than the other two groups during the last 4 min of the test 
at dawn (CT 22–01). Data are given as the means ± the SEM (n = 6–7 per 
group; *P < 0.05 versus Group A). (C) Frequency of attack bites (fighting 
behavior) against a male intruder for 5 min in the aggression test. No 
significant differences were observed between the three groups of mice. 
Data are given as the means ± the SEM (n = 6–7 per group). (D) Schematic 
diagram of a brain coronal section and region of interest (visually indicated 
by a red circle with a diagonal line) of the NAc. (E) Group C mice showed 
strong ∆Fos B mRNA expression in the NAc at dusk (CT 12–14). Data were 
normalized to GAPDH mRNA levels, where the mean value of ∆Fos B 
expression in Group A at 0 h (dawn) was set to 1. Data are given as the 


























Figure 20. Sucrose bingeing induces Nurr1 expression in the NAc. 
Transcriptional levels of genes of interest (Nurr1, Rev-erbα, RORα, and TH) 
were evaluated in the NAc at dawn (CT 0) and dusk (CT 12). No statistically 
significant differences were observed among Groups A, B, and C, except 
for elevated Nurr1 mRNA levels in Group C at dusk. Data were normalized 
to GAPDH mRNA levels, where the mean value of expression for each 
gene in Group A at 0 h (dawn) was set to 1. Data are given as the means ± 



































Figure 21. Profiles of circadian and DAergic-related genes in the NAc. 
Expression of genes of interest in Groups A, B, and C. Data were 
normalized to GAPDH mRNA levels, where the mean value for each gene 
in Group A at 0 h was set to 1, and are given as the means ± the SEM (n = 




























Figure 22. Reduction of abnormal Nurr1 expression by Rev-erbα 
upregulation and liver fat metabolism after sucrose withdrawal. (A) 
Pattern of sucrose consumption and ∆Fos B expression in sucrose-
bingeing mice (Group C) after 10 days of sucrose withdrawal. After 
withdrawal, the mice no longer overconsumed 10% sucrose. ∆Fos B 
expression in the NAc was higher in Group C than in Groups A and B, but 
reverted to nearly normal levels after sucrose withdrawal. Expression data 
were normalized to GAPDH mRNA levels, where the mean value for each 
gene in Group A at 0 h (dawn) was set to 1. Data are given as the means ± 
the SEM (n = 3–4 per group). (B) Effects of sucrose withdrawal on the 
expression of Nurr1, Rev-erbα, RORα, and TH mRNAs in the NAc at dawn 
and dusk. Rev-erbα was markedly upregulated after sucrose withdrawal at 
dusk, while Nurr1/RORα expression was downregulated. Data were 
normalized to GAPDH mRNA levels as above, and are given as the means 
± the SEM (n = 3–4 per group; **P < 0.01, *P < 0.05 versus Group A). (C) 
Lipid metabolism-related gene expression in the liver. Sucrose 
overconsumption led to induction of ACC mRNA expression, but expression 
returned to normal levels following the induction of fat oxidation genes 
(PPARα and CPT1α) after sucrose withdrawal. Data normalized to GAPDH 
mRNA levels are given as the means ± the SEM (n = 3–4 per group; **P < 

























Figure 23. Withdrawal effects on the transcriptional activity of 
circadian or DAergic-related genes in the NAc (Groups C and C’). 
Comparison of gene expression patterns in the NAc between Groups C and 
C’. Data were normalized to GAPDH mRNA levels, where the mean value 
for each gene in Group A at 0 h was set to 1, and are given as the means ± 
the SEM (n = 3–4 for each group; **P < 0.01 compared with Group C mice). 

































Figure 24. Sucrose-bingeing mice adjust their activity rhythm to a 
sucrose cue, even under constant dark conditions. (A) Representative 
double-plot actograms under 12 h/12 h LD and 12 h/12 h DD conditions. 
Activity rhythms under the LD cycle over 40 days with experimental 
treatment and under the DD cycle over 20 days without treatment are 
shown. (B) Food or fluid consumption was measured in each group of mice 
for 40 days with running wheel activity under the LD cycle. Data are given 




























Here, I present an analysis of the molecular characteristics of reward 
circuits, based on the circadian-focused perspective currently used in BED 
research. This study hypothesizes that the Rev-erbα acts as a regulator 
preventing Nurr1 overexpression in the NAc of sucrose-bingeing mice, 
restoring the balance of reward activity. Sucrose withdrawal triggers 
downregulation of Nurr1 by through increased expression of Rev-erbα. 
Although several studies have attempted to reveal molecular links between 
the molecular architecture of the circadian clock and the DA system, I 
provide the first evidence that the circadian nuclear receptor, Rev-erbα, 
functions in the reward pathway, especially in the NAc. 
Patients with BED commonly suffer from dysfunctional behavior and 
metabolic abnormalities (Hone-Blanchet et al., 2014). Diverse behavioral 
changes have been observed in rodent models of sucrose bingeing (Avena 
et al., 2008). Certain somatic symptoms, including behavioral 
manifestations of anxiety and depression, are escalated by sucrose 
withdrawal or deprivation in sucrose-bingeing mice. Short-term food 
deprivation can maximize the reward effect of sucrose (Colantuoni et al., 
2002). By contrast, withdrawal is often used as a simple therapy to abolish 
the effects of an addictive substance. Here, I found that short-term sucrose 
deprivation (1 day) amplified BED symptoms (Fig. 19), whereas a relatively 




seeking behavior (Fig. 22A). Because sucrose bingeing may be more easily 
managed than cravings for drugs or nicotine, it (and BED) could be more 
readily reversed with appropriate withdrawal therapy. 
Accumulating evidence implies that mutant mice with defective 
circadian clock genes suffer from cognitive dysfunction, anxiety disorders, 
and sensitivity to psychostimulant substances concomitant with altered 
DAergic signaling (Bundel et al., 2013; McClung et al., 2005; Aumann et al., 
2011). Given that molecular clock components affect basal reward 
responses to a preferred substance like sucrose, behavior alterations in 
sucrose-bingeing mice must be approached at different time points, day 
and night. In this study, anxiety- and depression-like behaviors exhibited by 
the mice in Group C appeared at different times of day, but this was not the 
case for aggression (Fig. 19A and 19B). These data suggest that 
chronotherapy may be appropriate for behavioral modification in sucrose-
bingeing mice. 
Despite emerging evidence supporting the importance of the circadian 
clock components in DAergic signal transmission, it is still unknown how 
these components affect reward pathway at the transcriptional level. I found 
that mRNA upregulation of the circadian nuclear receptor, Rev-erbα, 
attenuated abnormally amplified Nurr1 expression in the NAc during 
sucrose withdrawal. At that time, transcripts of RORα, a competitor of Rev-
erbα in the molecular clock machinery, decreased in abundance, possibly 
as a result of Rev-erbα overexpression. Considering the Nurr1 and Rev-




(Chung et al., 2014), Rev-erbα may defend against alteration of Nurr1, or 
its hypersensitivity. Intriguingly, TH expression did not response to these 
alterations. According to the previous reports, TH transcription in the brain 
can also be controlled by other transcription factors, such as ATF-2 and α-
synuclein (Suzuki et al., 2002; Baptista et al., 2003) as well as Nurr1 and 
Rev-erbα. I suspect that they may be altered for preserving TH activity and 
DA homeostasis in the NAc in response to sucrose overconsumption. All of 
these alterations can influence the dynamics and networking properties of 
the reward system. Moreover, reward pathway includes the VTA, amygdala, 
and hippocampus as well as the NAc. When an individual is exposed to 
additive substance like sugar, the VTA DAergic neurons are modulated by 
the activity of GABAergic neurons which contributes to the overall change 
in the DA level. It suggests that total TH tone in the NAc of sucrose 
bingeing mouse can be determined by diverse inputs from them.   
Food acts as a synchronizer to regulate diverse anticipatory activities in 
the brain and peripheral tissues, affecting physiological rhythmicity (Challet 
et al., 2003). Because feeding cues are not as strong as light cues, food 
entrainment can be masked by a light source. I demonstrated that 
compulsive sucrose overconsumption altered wheel running activity 
rhythms in the absence of the light (Fig. 24A). Although sucrose-bingeing 
mice showed normal actograms during the LD cycle, abnormal activity 
rhythms were observed in sucrose-bingeing mice subjected to the DD cycle 
relative to control mice under the same conditions. I hypothesize that 




synchronize their activity rhythm based on the sucrose cue when light is 
absent. 
Several studies claim that sugar-bingeing mice control their body weight 
by eating less food in place of sucrose overconsumption, whereas other 
studies claim that sucrose binges lead to weight gain (Hoebel et al., 2009). 
I found that compulsive sucrose overconsumption accelerated body weight 
gain and fatty liver syndrome (Fig. 18C and 23C). Nonalcoholic fatty liver 
(NAFLD) is frequently associated with obesity, type 2 diabetes mellitus, and 
dyslipidemia (Teli et al., 1995). Epidemiologic studies show that NAFLD 
induces hyperinsulinemia through ACC activation and thereby directly 
promotes fat accumulation in hepatocytes (Uyeda et al., 2006). Because 
enhanced ACC activity in the liver is associated with increased sucrose 
consumption, it is reasonable to speculate that body weight gain in 
sucrose-bingeing mice may result from impaired fat metabolism. Here, 
elevated ACC mRNA levels returned to normal during a period of sucrose 
withdrawal. This spike and recovery in ACC expression was followed by an 
increase in the expression of fat oxidation-related genes (PPARα and 
CPT1α). Interestingly, Group B mice, which received no sucrose reward, 
lost weight during the testing period. Food deprivation can activate the 
hypothalamic/pituitary/ adrenal axis by inducing stress and expression of 
neural peptides (e.g., neuropeptide Y) in the hypothalamus (Ponsalle et al., 
1992). These changes may promote excessive food intake. Accordingly, it 
is unclear why Group B, despite sufficient energy intake, lost weight 




In conclusion, this study demonstrated that compulsive sucrose-seeking 
behavior can lead to variations in gene expression, especially upregulation 
of Nurr1 mRNA in the NAc. Under sucrose withdrawal conditions, increased 
levels of Rev-erbα appear to control Nurr1 hyperactivity. Upregulation of 
Rev-erbα also suppresses RORα expression. These findings suggest that 
sucrose-bingeing mice suffer from fluctuating fat metabolism and altered 
activity rhythm. Finally, I propose that the Rev-erbα gene may serve as a 
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Rev-erbα 조절물질 발굴과 도파민 보상 회로에서의  
일주기 기능에 대한 연구 
 
이 지 연 
 
인간을 포함한 대부분의 생명체는 조직 및 세포 수준에서 약 24 시간 
주기성의 생리학적이고 행동학적인 체내 생체 시계 시스템을 유지하고 
있다. 생체 시계 시스템은 뇌의 시신경교차상핵 (suprachiasmatic nucleus; 
SCN)에 위치하는 중추시계와 국부 및 말초 시계에 의해 계층적인 구조
로 구성되어 있다. 이 시스템은 Bmal1, Clock, Per1/2/3, Cry1/2, Rev-erbα, 
Rorα와 같은 일련의 생체시계 조절 유전자들로 구성되어 있다. 최근의 




할 뿐만 아니라 각종 신진대사 및 행동학적 수준에서의 현상들에 큰 영
향을 미치고 있음을 보고하고 있다. 특히 최근 Rev-erbα 유전자가 가지
는 다형성에 대한 연구가 활발히 진행되고 있고, 정신분열증, 조울증, 두
려움을 포함하는 각종 정서질환과 다양한 대사성 질환 측면에서 Rev-erb
α의 필수적인 역할이 대두되고 있다. 연구 결과에 의하면 Rev-erbα는 도
파민 생합성을 촉진하는 Nurr1 유전자와 경쟁적인 활성을 보이며 전체
적인 도파민 수준을 조절한다. 따라서, 합성된 특이 화합물을 사용하여 
Rev-erbα의 활성을 조절하는 일은 비정상적인 생체시계에 의해 유도된 
다양한 신진대사 관련 질환 뿐만 아니라 중독, 정서 질환, 파킨슨 질병 
등을 아우르는 도파민 대사 관련 질환 역시 치료 가능함을 제시해 줄 것
이다.  
제 1장에서는, Rev-erbα 활성 조절이 가능한 신규 화합물을 발굴하고, 
이 화합물의 처리에 의해 생체시계 수준에서의 활성이 효과적으로 조절
되는지 연구하였다. Rev-erbα가 접합하는 특이 영역인 RORE의 활성을 
반영하는 리포터를 제작하고, 이를 사용하여 신약 후보 물질로 구성된 




중 KK-S6 화합물은 RORE를 매개하는 전사활성을 효과적으로 감소시켰
고, 전사 수준 뿐만 아니라 단백질 수준에서 역시 생체시계 중심 분자인 
Bmal1을 감소시켰다. 이러한 KK-S6의 활성은 Rev-erbα가 결핍된 세포 
내에서 소멸되는 반면 Rev-erbα를 과발현 시킨 세포주에서는 증폭되었
다. 이를 통해 KK-S6는 Rev-erbα에 의존적인 활성을 갖는 것으로 추정
된다. 이 화합물은 세포 수준에서 뿐만 아니라 조직 수준에서 역시 생체 
시계 진폭 변화에 효과적인 활성을 보였다. 더욱이 Rev-erbα 하위 수준
의 여러 유전자들은 KK-S6의 처리에 의해 효과적으로 조절되었다. 이러
한 결과들은 Rev-erbα 활성 조절 신규 화합물인 KK-S6이 비정상적인 생
체시계 관련 질병들을 Rev-erbα 활성을 증폭시킴으로써 효과적으로 조
절해 낼 수 있는 치료제로써의 가능성을 제기한다. 
제 2장에서는, 과도한 설탕물 탐닉이 유도된 생쥐 모델을 사용하여 도
파민 시스템이 관장하는 보상 회로에서의 Rev-erbα 역할을 조사하였다. 
반복적으로 설탕물을 탐닉하는 생쥐의 행동학적 양상은 높은 수준의 두
려움 및 우울증 관련 행동들의 유발을 촉진하였다. 또한 유전학적 관점




신경핵에서 높은 수준으로 발현하고 있었고 이와 동시에 Nurr1 유전자
의 발현 역시 같은 시간대에 급격하게 증가되어 있었다. 이러한 현상은 
설탕물 섭취를 중단시킨 후 Rev-erbα 유전자의 발현이 증가하면서 다시
금 정상적으로 회복되었으나 TH의 변화를 동반하지는 않았다. 또한 설탕
물에 대한 보상은 빛이 없는 조건에서 생쥐의 활성 리듬을 효과적으로 
조절하였고, 간 내 지방대사에까지 영향을 미치고 있었다. 상기한 연구결
과를 통해 Rev-erbα 는 비정상적인 보상 활동에 의해 뒤바뀐 도파민 대
사 및 민감도에 대하여 유발되는 일련의 항상성 유지 활동에 있어서 일
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